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In radiation therapy, interfraction organ motion introduces a level of geometric
uncertainty into the planning process. Plans, which are typically based upon a single
instance of anatomy, must be robust against daily anatomical variations.

For this

problem, a model of the magnitude, direction, and likelihood of deformation is useful. In
this thesis, principal component analysis (PCA) is used to statistically model the 3D
organ motion for 19 prostate cancer patients, each with 8-13 fractional computed
tomography (CT) images.

Deformable image registration and the resultant

displacement vector fields (DVFs) are used to quantify the interfraction systematic and
random motion. By applying the PCA technique to the random DVFs, principal modes
of random tissue deformation were determined for each patient, and a method for
sampling synthetic random DVFs was developed.

The PCA model was then extended to describe the principal modes of systematic
and random organ motion for the population of patients. A leave-one-out study tested
both the systematic and random motion model’s ability to represent PCA training set
DVFs. The random and systematic DVF PCA models allowed the reconstruction of
these data with absolute mean errors between 0.5-0.9 mm and 1-2 mm, respectively.
To the best of the author’s knowledge, this study is the first successful effort to build a
fully 3D statistical PCA model of systematic tissue deformation in a population of
patients.
By sampling synthetic systematic and random errors, organ occupancy maps
were created for bony and prostate-centroid patient setup processes. By thresholding
these maps, PCA-based planning target volume (PTV) was created and tested against
conventional margin recipes (van Herk for bony alignment and 5 mm fixed [3 mm
posterior] margin for centroid alignment) in a virtual clinical trial for low-risk prostate
cancer.

Deformably accumulated delivered dose served as a surrogate for clinical

outcome. For the bony landmark setup subtrial, the PCA PTV significantly (p<0.05)
reduced D30, D20, and D5 to bladder and D50 to rectum, while increasing rectal D20 and
D5. For the centroid-aligned setup, the PCA PTV significantly reduced all bladder DVH
metrics and trended to lower rectal toxicity metrics. All PTVs covered the prostate with
the prescription dose.

1.

Introduction

The goal of fractionated definitive radiotherapy is to deliver a sufficient dose to kill
all cancerous tumor cells while minimizing the risk of toxicity to the surrounding healthy
tissue.

Both cancerous and healthy tissues exhibit day-to-day variations in organ

position, shape, and volume. These changes in 3D anatomy (referred to collectively as
organ motion in this thesis) can be classified as either intra- or interfraction motions.
Intrafraction motion is the change in anatomy over the course of a single daily
treatment. Interfraction motion is the change in anatomy from day to day. The latter
issue will be the focus of this thesis.
Anatomical motion and deformation introduces geometric uncertainty into the
radiation therapy planning process.

Conventional planning involves acquiring a 3D

computed tomography (CT) image of the patient to plan a radiation treatment. This CT
image only captures a “snapshot” of the patient, or how the anatomy looks at a
particular moment in time. Plans based on these snapshots have the potential to be
suboptimal for treatment as any organ motion that occurs subsequent to treatment
planning can result in target miss and/or healthy tissue overdose.
Ideally, online planning would be used for all radiation therapy treatments.
Online planning involves imaging the patient in the treatment position prior to each
fraction. While the patient is waiting, the relevant anatomy would be contoured and a
plan of the day developed and delivered based on this current anatomical instance.
Assuming the patient remained stationary during this process, online adaptive radiation
1

therapy would eliminate any errors introduced by interfraction motion.

Although

intrafraction motion would not be accounted for, online adaptive radiation therapy would
be extremely useful in sites where interfraction motion dominates organ motion, such as
the prostate and cervix.1-3 This could also be helpful in sites such as head and neck,
where there exists a temporal dependence of interfraction motion due to patient weight
loss and tumor regression.4-7

In prostate radiation therapy, Ghilezan8 showed that

idealized daily online planning provided, on average, a 13% increase in the therapeutic
ratio. Therapeutic ratio is the ratio of tumor control to radiation-induced normal tissue
toxicity.

Ghilezan defined therapeutic ratio as the maximum generalized equivalent

uniform dose (gEUD) to the prostate without exceeding specified organ at risk (OAR)
toxicity quantified in terms of gEUD. For prostate treatment, the dose-limiting organ
was found to be the rectum. Additionally, the individual benefit in therapeutic ratio
varied widely (SD=9.7%) from patient to patient. Still, approximately one-third of the
patients in the Ghilezan study benefited from online adaptive planning, with therapeutic
ratio increases of at least 15%.8
However, such idealized online planning has a number of drawbacks, including
the amount of time needed to create the daily plan. The patient must be imaged, the
target and avoidance structures delineated, and an optimized plan created, all with the
patient remaining in the treatment position.

This lengthy process can lead to

unacceptable patient discomfort and may seriously hinder patient throughput in the
clinic. For these reasons, online planning is currently impractical for daily patient care.
While improvements are being made to hasten the online planning process,9-11
alternative methods for accounting for anatomical uncertainty must be utilized.

2

Recent advances in in-room imaging systems, such as cone beam CT (CBCT)
and CT-on-rails, have improved target localization in radiation therapy.12,13 Imaging
immediately before and during treatment is becoming routine and reduces patient setup
errors. These images are used to rigidly align the patient’s treatment anatomy with his
or her planning anatomy by means of couch shifts and can be based on bony anatomy,
soft tissue landmarks, or implanted markers within the tumor. While such deterministic
corrections can improve the therapeutic ratio, they cannot account for all sources of
anatomical uncertainty.14 One common deterministic correction currently practiced is
online setup to radio opaque fiducial markers implanted directly into the prostate.
However, not all impacts of organ motion and tissue deformation can be fully accounted
for using translational and rotational alignment, e.g., deformations of the CTV and
changes in shape and relative position of OARs. These residual uncertainties must be
accounted for by other means. Generally, this is accomplished by creating an initial
treatment plan that is designed to be robust against daily variations in the patient’s
anatomy.
To create such a plan, some form of probabilistic treatment planning (PTP) is
usually used. PTP is the process of maximizing the likelihood that treatment objectives
are met in situations of anatomical uncertainty. A simple and nearly universally used
PTP approach is the use of a margin. The International Commission of Radiation Units
and Measurement (ICRU) Report 50 has defined several concepts relevant to
margins,15 the first of which is gross tumor volume (GTV). The GTV is the extent of
malignancy that can be determined through physical examination, imaging, or a
combination of the two. The CTV is the GTV plus any presumed microscopic extension

3

of the disease. In addition to the GTV, the treatment plan must include the CTV, as the
CTV is presumed to contain malignant cells.

In practice, this is determined by

measuring the GTV and expanding the volume with a margin or to adjacent anatomical
boundaries that delimit the potential spread of subclinical disease. The final volume is
the ICRU 50 defined planning target volume (PTV). The PTV is a geometrical concept
that is used to account for possible geometric uncertainties, including patient setup
errors, beam setup errors, and organ movement and deformation. The PTV is generally
taken as an expansion of the CTV using some margin that is determined to ensure
adequate coverage of the CTV, in the event of anatomical motion.
The use of a margin to create the PTV represents a tradeoff between target
coverage and normal tissue toxicity. The expansion must be large enough so the PTV
encompasses the expected range of daily anatomic presentations. A larger margin will
ensure the plan is more robust against tumor miss, but it may subject larger volumes of
the OARs to unnecessarily large doses, thereby reducing the therapeutic ratio.
Different strategies have been proposed to estimate the optimal margin, using
knowledge of the underlying organ motion to create a PTV that encompasses a large
percentage of possible daily anatomies. These margin calculations are statistical in
nature, meant to ensure a high probability of target coverage. For this reason, this
thesis considers margin-based planning to be the simplest of PTP techniques. Several
of these strategies will be discussed later in this chapter.
More advanced PTP methods directly incorporate probabilistic criteria into the
planning process. Unlike traditional objective functions, which optimize on dose criteria
for both the PTV and OARs, PTP optimizes on the likelihood of these criteria being met

4

in the presence of organ motion. All PTP methods require a statistical organ motion
model. A PTP method is only as good as its underlying assumption of the magnitude,
direction, and likelihood of different daily anatomical configurations. The goal of this
thesis is to develop a 3D statistical model that includes both OARs and CTVs.
Modeling—specifically, statistical modeling of the patient’s anatomical changes—
is the most effective strategy for accounting for those errors for which deterministic
correction is not technically feasible or cost effective. A model of anatomical motion, as
the term is used in this thesis, is a statistical measure of the probability of a given
anatomical instance over the course of radiation therapy. Here, an anatomical instance
is represented by a voxel-by-voxel mapping between the planning anatomy and the
daily treatment anatomy. This mapping is characterized by a displacement vector field
(DVF), a general measure of organ motion. A model gives the probability of all possible
deformed states, as described by DVFs and can provide valuable information to the
planning process when the treatment-day anatomy cannot be easily known.

This

information can be directly incorporated into the planning process.
Statistical motion models can be used for any treatment site where there is organ
motion.

Hereafter, “organ motion” will refer to any displacement or deformation

between the patient’s treatment day anatomy and his or her planning anatomy. The
work presented in this thesis is mainly focused on the development of a new model and
its potential clinical applications. The focus is on the anatomy critical to the treatment of
low-risk prostate cancer, specifically, the prostate, bladder, and the rectum. This threeorgan system in the male pelvis was chosen for several reasons. These organs move
relative to bony anatomy, their movement is correlated with bladder and rectal filling,16,17

5

and the intrafraction motion is smaller in relation to the interfraction motion. Britton et al.
reported the mean interfractional motion of an implanted fiducial to be 1.76, 3.14, and
3.78 mm in the left-right, superior-inferior, and anterior-posterior directions, respectively.
This compares to the measured intrafraction motion of 0.45, 1.08, and 1.45 mm.2 Su et
al. separated the inter- and intrafractional motion into its systematic and random
components. Their results are shown in Table 1.1
Table 1: Comparison of the inter- and intrafraction motion of the prostate as measured by Su et
al.1

LR

SI

AP

Systematic Error (mm)

2.3

3.4

4.7

Random Error (mm)

3.7

2.7

3.5

Systematic Error (mm)

0.3

0.5

0.6

Random Error (mm)

0.7

1.4

1.9

Interfraction

Intrafraction
Abbreviations: LR=left/right. SI=superior/inferior. AP=anterior/posterior.

Additionally, the treatment target (the whole prostate) has a stable (±10%) volume over
the treatment course.17 This reduces the possibility of any time trend in the anatomy
over the course of treatment, removing an unnecessary extra layer of complexity to any
modeling attempt.
This work is intended to show the clinical benefit of incorporating statistical
motion modeling of the prostate, bladder, and rectum into the treatment planning
process. This could be extended to high-risk prostate cancer patients by including
seminal vesicles and pelvic lymph nodes in the model. Results from this work could
also directly benefit intermediate and high-risk prostate cancer patients, as a prostate6

only boost is a very common part of their treatment. This work could also be adapted
for use in focal radiation therapy.

The model could be used to identify the daily

locations of subregions of the prostate containing a higher concentration of malignant
cells. This region could then be boosted to a higher dose, with the model being used to
ensure coverage. This model could also be extended to different treatment sites, such
as head and neck, and pancreas.
1.1.

External beam radiation therapy of prostate cancer
Currently, there are a number of treatment options for patients diagnosed with

prostate cancer.

Some of the most common include watchful waiting, radical

prostatectomy, low dose rate brachytherapy (permanent seed implant), and external
beam radiation therapy (EBRT), or some combination thereof.

The choice and

effectiveness of these options are highly dependent on the tumor’s T-stage and
biological

aggressiveness

pretreatment

(conventionally

prostate-specific

antigen

measured

[PSA]

level).

by

Gleason
Broadly,

score
the

and

National

Comprehensive Cancer Network (NCCN) classifies prostate cancer into low,
intermediate, and high risk.18 In both low and intermediate risk prostate cancer, the
disease must be clinically staged as prostate-confined. A tumor falls into the high-risk
category if it invades adjacent structures such as the seminal vesicles and pelvic lymph
nodes.

However, very high Gleason score (>7) or pretreatment PSA with clinical

evidence of spread outside the prostate can also qualify the patient for high-risk status.
As this thesis is focused on low-risk prostate cancer, discussion will be limited to
the current interventions and their outcomes in this context.

Currently, radical

prostatectomy, brachytherapy, and EBRT all have very favorable control rates. Ten7

year follow-ups after 3D conformal radiation therapy (CRT) EBRT showed a 93% rate of
freedom from biochemical failure (bNED).19 Memorial Sloan Kettering has shown that
by using intensity-modulated radiation therapy (IMRT) to deliver a highly conformal
escalated dose (86.4 Gy), seven-year bNED rates for low-risk prostate cancer were as
high as 99%.20 A separate study showed comparable results between 3D CRT EBRT
and radical prostatectomy.21 Seven- and 10-year studies for brachytherapy have shown
a 95% and 94.1% biochemical relapse-free survival, respectively.22,23
While each modality exhibits excellent control rates, each option has drawbacks
and associated side effects. Not all patients are candidates for radical prostatectomy or
brachytherapy, as both procedures are invasive. Both procedures are also dependent
on the skill of the surgeon. EBRT is noninvasive and less dependent on physician skill.
All procedures are associated with varying degrees of short- and long-term difficulties in
urinary and sexual function.24-26
For EBRT, one study of 151 patients treated to 78 Gy reported grade 2 or higher
bladder toxicities of 10% and grade 2 or higher rectal toxicities of 26%.27 Arguably,
EBRT has the largest potential to improve toxicity rates by limiting the dose to
surrounding OARs. In a literature review, Staffurth reported that by using the more
conformal approach of IMRT instead of 3D CRT, grade ≥2 gastrointestinal toxicities
were reduced to from 20% in 3D CRT to 6% using IMRT.28 In the same review, it was
noted that there were no significant differences in genitourinary toxicity between 3D
CRT (median incidence of 18%) and IMRT (median incidence of 21%). This suggests
that there is still a need for more optimal treatment that can help spare the bladder.
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Combining highly conformal dose delivery with better knowledge of the target
location has the potential to further reduce toxicity. Anatomical uncertainty requires the
plan to target a larger volume, increasing the bladder and rectum volumes that receive
the full prescription dose.

One hypothesis of this thesis is that a completely 3D

statistical model of this three-organ system to accommodate targeting uncertainty due
to residual organ motion not controlled by a daily deterministic IGRT correction will
reduce OAR doses needed without comprising target coverage.
1.2.

Previous work on statistical management of anatomical uncertainty
In this thesis, targeting error is defined as the linear difference between

corresponding anatomical locations in the patient’s planning anatomy at the time of
simulation and the patient’s anatomy at the time of treatment. This error arises from
various sources, including setup errors, organ displacement, and organ/soft tissue
deformation. Setup errors are any errors introduced by suboptimal patient positioning in
the treatment room. Patient positioning can be done in several ways. Traditionally,
patients have been positioned on the treatment table by aligning skin tattoos with inroom lasers in conjunction with initial and weekly port films or x-rays.

With the

widespread use of in-room imaging, further target alignment has become quite
common. To align on bony landmarks, x-ray projections or CBCT are used to image the
patient, and the bones are then used to reposition the patient to match the planning
image. This is fairly straightforward as the skeletal structure of the patient does not
greatly change from day to day. In prostate cancer, is also common to align on radio
opaque fiducial markers implanted directly into the prostate. In-room x-rays are then
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taken to align the patient based on these intraprostatic markers. This technique not
only attempts to partly correct for setup errors, but also organ displacements.
Translational corrections are made to account for both setup errors (errors due to
setup alone) and organ motion.

Both tattoo and bony alignment assume that the

patient’s soft tissue is fixed in relation to the skin and bones. This is not the case, as
differences have been found between tattoo (with weekly portal image verification) and
bony alignment setups.29 There have also been reported differences between bony and
marker based setup.30-32 Fiducial marker setup has the advantage of aligning to a point
within the target (prostate) that is to be treated, correcting for more organ motion than a
bony-aligned setup. Marker-based setup has some associated uncertainty: Changes in
inter-marker distances on the order of 1.5 mm due to prostate deformation and seed
migration have been reported.33,34

Studies have shown differences in the prostate

surface of over 1 mm even after post marker alignment.35,36 A fiducial alignment also
does not account for motion in the volumes surrounding the prostate,37 such as the
OARs.

Nearly all online setup techniques use a translation-only strategy, ignoring

rotations and deformation. None of these methods can fully account for daily organ
motion. Therefore, strategies to account for the residual error must be incorporated into
the planning.
In prostate cancer, the most common approach for managing residual anatomical
uncertainty is the use of a PTV margin.

Since the introduction of PTVs, different

formulas for their associated margins have been proposed. For prostate treatment, the
two most well-known formulas are those constructed by Stroom38 and van Herk.39 Both
divide the targeting error they are accounting for into systematic and random
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components.

Systematic error is the displacement relating the patient’s planning

anatomy to the patient’s mean anatomy.

Random error is the daily residual

displacement around the systematic error. Each type of error has a different effect on
the delivered dose distribution. Random errors are less worrisome when compared to
systematic, as they create a blurring of the dose distribution and tend to “wash out” over
the course of many fractions.40 Systematic errors are more serious, as they manifest as
shifts in the cumulative dose distribution.41 Both Stroom and van Herk formulas are
based on statistical models and are designed to meet certain CTV coverage criteria
over the course of treatment.
Both formulas are designed to use the statistical motion characteristics of a
population of similar patients.

The population statistics used in their organ motion

modeling were the standard deviation of the systematic error distribution,  , and that of
the random error distribution,  .

In order to calculate these population statistics,

Stroom and van Herk assumed any targeting error can be described by one systematic
error and one random error. Also assumed is that the prostate is a rigid body that can
only translate, ignoring deformation.
Both formulas were built to probabilistically ensure dose coverage.

Stroom

designed his margin to ensure at least 95% of the prescribed dose is delivered to an
average of 99% of the CTV for a prostate, cervix, and lung clinical plan. To accomplish
this, target coverage probability is computed using the inputs  and  . This calculation
is then coupled with an actual 3D CRT dose distribution (for prostate, the 3 field box
technique is used) to meet the stated criteria. This method includes translational and
rotational errors. The van Herk method was aimed at providing a minimum of 95% of
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the prescribed dose to the entire CTV for 90% of patients. To account for systematic
errors, this method uses purely coverage-based criteria, ignoring the dose distribution.
The dose distribution is taken into account for random errors, where a conformal dose
distribution with a 3.2 mm beam penumbra is assumed in the commonly used
formulation. This method includes translational errors only.
Both formulas take into account setup error as well as rigid tumor motion. For
example, in the prostate, a bony-aligned setup would include the systematic and
random errors of the alignment as well as the systematic and random errors of the
prostate’s movement in relation to the bony anatomy. As alignment to intraprostatic
fiducial markers becomes more popular, these formulas lose value. The systematic and
random errors become zero as the markers are assumed to move rigidly with the rest of
the prostate. In these instances, there is still a need for a margin to account for the
deformations and rotations of the prostate.
Alternative methods have been reported that account for the residual anatomical
uncertainty after deterministic corrections. Such methods incorporate the use of imageguided adaptive radiation therapy (IGART). IGART uses data from patient images to
adapt the original treatment plan based on anatomical characteristics of the specific
individual. A well-documented clinical variation of IGART is Beaumont-style adaptive
radiation therapy (ART), hereafter referred to as “Beaumont ART.”

This method,

developed by Yan et al., estimates the patient-specific systematic error and random
error distribution,  , based on a limited number of fractions, k , usually taken to be 5
days.42,43 In their method, CT simulations are taken during the first k days of treatment,
with the CTV contoured on all images. The images are then aligned on bony anatomy,

12

and a convex hull is created from the union of these contours. This structure is referred
to as the PTVo  k  , and compensates for internal target motion. During the same time,
in-room projections are taken directly prior to treatment and compared to digitally
reconstructed radiographs (DRRs) to find the rigid shifts of bony anatomy. From these
projections, systematic and random error distributions are determined as the average
and standard deviation of the shifts, respectively, using a Kalman prediction method to
estimate the true values from the measurements. The setup position is then modified to
account for the systematic error, while a margin is added to PTVo  k  to compensate for
the random errors. The PTVo  k  plus the margin is referred to as the clinical PTV, or
cl-PTV.

The patient is then replanned and treated based on the derived cl-PTV.

Beaumont ART has been shown to give a maximum dose reduction of 2% or less to the
CTV for at least 80% of patients in IMRT cases.42 This means that dose coverage to
the CTV is not compromised by planning using the cl-PTV derived from a small subset
of measurements taken in the first week of treatment.
Beaumont ART uses the relatively simple idea of a convex hull in order to model
the possible prostate deformations specific to an individual patient. This method takes
into account some of the possible deformations of the prostate, but fails to account for
the surrounding organs at risk, such as the bladder and rectum. In addition, Beaumont
ART gives no guidance on how to plan and treat the patient during the data
accumulation period. It also relies on estimating a PTV from a limited dataset. Due to
the small statistical sample size (5 days of images), additional estimation of the residual
anatomical uncertainty is needed. Beaumont ART provides little information on how the
prostate deforms and no information on the deformations of any OARs. A completely
13

3D statistical model of the male pelvis would provide such information. Incorporating
knowledge of OAR motion, target coverage, and critical structure avoidance could
improve the therapeutic ratio.
1.3.

Deformable image registration (DIR)
The most complete, currently available characterization of organ motion between

two anatomic states of a given patient is deformable image registration (DIR). DIR
computes the transformation that maps points in a source image to their corresponding
voxels in the target image. The resultant DVF quantifies the net displacement of a
tissue subvolume during the time interval between acquisitions of the two images. As
multiple images are acquired over the course of treatment, each new image can be
registered to a common image. This produces multiple measurements of the patient’s
interfraction motion.

With enough samples, these DVFs can be used to look for

possible patterns in tissue motion over the entire 3D volume contained in the images.
Fundamentally, DIR is an optimization problem.

The underlying objective

function that drives the registration ultimately determines the resultant transformation.
DIR generally tries to determine the transformation that minimizes the intensity
differences between the two input images, but often includes other criteria to ensure a
realistic correspondence between the two images. Such criteria include regularization,
which can ensure a smooth and realistic image. In the end, any useful data derived
from deformable image registration are only as reliable as the DIR algorithm’s ability to
characterize the underlying anatomical motion.
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1.4.

Principal components analysis (PCA)
Extracting useful information from a collection of DVFs is a difficult task. Each

DVF is a data structure that can store 3D displacements of millions of voxels. The data
associated with these voxels are often highly correlated, however. The trajectory of a
given voxel over the course of treatment is likely to be similar to its neighboring voxels.
This correlation can be exploited using principal component analysis (PCA) in an
attempt to reduce the high dimensionality of the problem.
eigendecomposition of the covariance matrix of the data.

PCA is the

Each element of the

covariance matrix represents the covariance between two voxels, a measure of how
these variables change together. PCA is the eigendecomposition of this matrix, the
mathematical equivalent of a coordinate system transformation. The output is a basis
set of orthogonal eigenmodes. The first eigenmode, or most principal component, is the
basis vector on which one can project the greatest amount of variance in the data. The
second-most principal component is the orthogonal vector that can account for the most
amount of residual variance in the data, and so on.

Each eigenmode has a

corresponding eigenvalue. The eigenvalues are measures of how much variance in the
data is represented by its associated eigenmode.

Eigenmodes that represent little

variance (generally all those totaling <10%) in the original data can then be discarded,
further reducing the dimensionality. These eigenmodes are assumed to represent small
and unlikely modes of motion or possible noise in the data.
The resultant eigenmodes are a basis set for the PCA input data, meaning the
input data can be represented as a linear combination of these eigenmodes multiplied
by some scaling coefficient. As the eigenmodes are orthogonal, the distributions of their
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associated scaling coefficients are linearly independent from one another. For the input
data, the distribution of these coefficients is related to a normal distribution with a
standard deviation equal to the eigenvalue associated with the eigenmode.

In the

context of anatomical motion, the principal components are DVF-like structures that
represent the most likely independent patterns of motion in our dataset. Assuming the
initial dataset adequately represents the patient’s underlying physical motion, PCA also
has the ability to represent future deformations in the patient that are not included in the
initial training set.

This process is as simple as finding the corresponding scaling

coefficients for each eigenmode. These coefficients are calculated as the dot product of
the eigenmode and the original data.
In this work, the potential value in PCA lies with its ability to break down male
pelvic motion into the underlying dominant modes of motion. PCA also computes the
likelihood of a given deformation as the likelihood of selecting the associated scaling
coefficients. These measures of the magnitude, direction, and probability of motion can
be directly incorporated into the planning process. Larger margins can be implemented
in areas with high likelihood of large target deformation or displacement, and greater
efforts can be made to spare areas more likely to be occupied by deformed instances of
OARs. This knowledge could be used to optimize outcomes for individual patients and
for the patient population as a whole.
Previously, PCA characterizations of organ motion and anatomical changes have
been used to analyze and help diagnose diseases ranging from scoliosis to
Alzheimer’s.44,45 Less work has been done to explore the motion of the pelvic anatomy
in the treatment of prostate cancer. One work of note is the detailed statistical analysis
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done by Sohn.46

In this work, PCA was used to statistically model the surface

deformations of the three-organ system of the prostate, bladder, and rectum. For four
separate patients, the organ shapes were deformably registered to the average organ
system shape, and the principal eigenmodes of deformation were calculated, related to
the major geometrical modes of variation. The authors found that a patient’s organ
shapes could be reconstructed to within 1.3–2.0 mm using four principal modes. Their
results are of limited value to IGART applications, as they represent only surfaces of the
three organs mentioned. The rest of the anatomy (both inside and outside of the three
organs) was not modeled in their study. In addition, their analysis was patient-specific,
and they found no correlation between modes between patients.

Patient-specific

models have been proposed in other sites, most notably lung.47,48 In such models of the
prostate, numerous images are needed over the course of two or three weeks to fully
characterize the patient specific motion. Any intervention in treatment could only be
done after this initial data collection period.
This data collection problem is addressed by Budiarto et al.49 Although only
dealing with the shape of the prostate and seminal vesicles, a PCA technique was
outlined to incorporate population data into the analysis. Since systematic organ motion
error is unique for each patient’s treatment, population data is necessary in order to
model the distribution of systematic errors across a group of patients.

Using 18

patients, each with four DVFs, to build their training dataset, Budiarto et al. were able to
reconstruct the deformations of three patients not included in the training set, with the
prostate and seminal vesicle boundary displacements accurate to within 1.5 mm using
15 eigenmodes. Budiarto et al.’s study was limited to modeling the surfaces of the
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prostate and seminal vesicles. Ideally, a description of the anatomy as a whole is
desirable. This is especially important in prostate cancer, as the bladder and rectum
have greater magnitudes of deformation than the prostate. In the follow-up paper, this
population model was used to investigate the dosimetric effect of random errors.50 For
a single prostate case, they calculated the mean and standard deviation of the dose to
the prostate and seminal vesicles in the presence of random deformation errors. This
work was very limited in clinical usefulness, however. They admittedly ignored any
systematic deformation errors and their effect on the dose. Additionally, their analysis
used a single beam and incorporated only the single most dominant mode of motion
(representing only 34.7% of the whole spectrum energy). Their method for calculating
the mean and standard deviation of the dose was quite computationally expensive,
possibly limiting its direct use in the plan optimization process.
A population model for the entire 3D pelvic anatomy, and not just one with limited
organ shapes, would be of great benefit. The model could be incorporated into the
radiation therapy treatment planning process in a number of ways. For example, if the
model predicted a large probability of organ motion in a certain direction but very little in
another, the model could be used to create anisotropic margins that better spared
normal tissue and ensured greater coverage of the prostate.

Anatomical motion

statistics could also be incorporated into PTP. This process would use the population
model of the anatomical uncertainty to create a plan that maximizes the probability of
realizing tumor coverage and other treatment goals. The model would be based on
population data and would require no extra information of a patient other than his
planning CT.
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The potential danger of a population model is that it might not benefit every
patient. By definition, the goal of a population model in this context is to describe the
anatomical motion for most patients; however, patients with abnormal organ motion may
have their tumors underdosed while patients with little organ motion may have the
normal surrounding tissue unnecessarily overdosed.

This may be resolved in an

adaptive strategy, using a patient-specific model, to replan the patient treatment as
more individual data (e.g., daily CBCT images) are gathered.
1.5.

Novel research contributions and acknowledgements
The general goal of this thesis is to develop a process for statistically modeling

3D systematic and random tissue deformation that could, in principle, be applied to any
treatment site. The independent contributions of the writer (Douglas J. Vile) are as
follows. I, Douglas, have implemented a working tool for modeling both individual and
population organ motion, as characterized using DVFs.

This included creating a

detailed mathematical description of these models and creating a Matlab-based
computer code to implement the models. In this process, I determined a solution to the
problem of performing organ specific deformable registrations from one patient to
another, as well as developing DVF stitching techniques to be used in this work. These
inter-patient registrations were used in solving the problem of transporting patient
specific statistics to a reference anatomy. I am responsible for all evaluation of the
models developed in this thesis.
With the models in place, I proposed and implemented two virtual clinical trials
(VCTs) in order to demonstrate clinical utility. This was done in the context of radiation
therapy for low-risk prostate cancer. I also worked with Huijun Xu in order to implement
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patient-specific statistical modeling within the probabilistic treatment planning framework
of coverage optimized planning.
To my knowledge, this thesis presents the most complete statistical modeling of the
pelvic anatomy for patients undergoing definitive radiation therapy for prostate cancer.
This work includes the statistical modeling of individual patients as well as for a
population of patients, and is the first to report a fully 3D representation of systematic
and random error distributions of the pelvic organ motion. A novel method for creating
treatment planning margins is developed that is based on the population statistical
model.
The work in this thesis is the realization of project first proposed by Drs. Jeffrey
Williamson, Martin Murphy, and Ramesh Ramakrishnan in a Program Project Grant
application last submitted to the NIH (P01CA116602) in 2006. That application
introduced the concept of using PCA to model statistical fluctuations of organ motion
through PCA modeling of DVFs describing both random and systematic organ motion.
Specifically, this work stems from Project 1 (Deformable Image Registration and
Reconstruction), Project 3 (Image-guided IMRT and Brachytherapy for Pelvic Tumors),
and Core B (Administration, Biostatistics, and Outcomes Modeling) of that research
grant.51-53

The author of this thesis gratefully acknowledges the guidance and

intellectual input received from Drs. Murphy, Christensen, and Williamson during the
course of this project. In addition, the author would like to thank Dr. Chet ford, who
computed many of the DVFs on which this work is based upon. Much gratitude is
expressed to the NKI for providing the CT images used in this thesis, to Dr. Jeffrey
Seibers for their processing, and to Dr. Elisabeth Weiss for contouring the images. The
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work in this thesis could not have been possible without use of research computing
framework (RCF) tools developed at VCU and their authors. This work specifically uses
the DVF generator, image and contour warping, and biological dose accumulator tools.
The author would also like to thank Ford Sleeman and Dr. Mirek Fatyga for their help
using these tools. Finally, the author would like to thank Dr. Nitai Mukhopadhyay of the
VCU Department of Biostatistics for his guidance on statistical methods utilized in this
work.
1.6.

Research aims and organization
Chapter 2 outlines the process through which I built a statistical PCA model using

a series of collected images for an individual patient. The dataset and methods used in
this entire research are described in depth.

Efforts to validate the method are

presented, verifying that the PCA model accurately describes the underlying patient
anatomy. Potential uses and applications of an individual model are also discussed.
Because little patient-specific data is available at the beginning of treatment,
there is not enough statistical power to create a patient-specific model. In Chapter 3, I
address this issue by describing the construction of a population model for the male
pelvic organ motion. The need for a common coordinate system in which to model the
anatomy is presented in detail. Any modeling errors were quantified as an assessment
of its potential use. The constructed model was used to calculate and compare  and


between two different patient setups.

A bony alignment patient setup and a

simulated fiducial marker setup was compared. Organ occupancy diagrams were also
calculated and compared for the two setups. This chapter is structured to align with a
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manuscript that is to be submitted for publication.

This manuscript is included in

Appendix B.
With the population model in place for both a bony and simulated fiducial-based
patient setup, an example of incorporating it into the treatment planning process is
outlined in Chapter 4.

This straightforward method involved using the occupancy

diagrams created in Chapter 3 to calculate an anisotropic margin for use in the planning
process.

This planning method was directly compared against current planning

techniques using the virtual clinical trial (VCT) framework. The VCT framework allowed
for the comparison of two planning techniques on the same patient data. Dose volume
histogram (DVH) metrics were used for the comparison of physical dose.
In Chapter 5, I discuss the limitations and the potential future uses of the
methods described in this thesis.

Topics include the potential adaptive planning

process by individualizing the patient treatment as well as extensions of the
methodology to other sites. This work is supplemented by two appendices. Appendix A
outlines the mathematical formalism of the PCA technique. Appendix B includes the
manuscript on the construction and validation of the population model.
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2.

2.1.

3D systematic and random targeting error and statistical modeling
of patient-specific anatomical deformations

Introduction
The anatomy of a single prostate cancer patient is never the same from

treatment day to treatment day. The bladder and rectum fill and empty, pressing on the
surrounding organs, causing shape deformation and displacement.

For the

displacement, a simple rigid shift of the patient’s treatment position can prove to be a
beneficial correction strategy.54,55

However, no rigid shift will be able to account

completely for deformation. Ideally, online replanning would be used to create a plan
specifically for that day’s anatomy. First, the patient would be set up in the treatment
position. An onboard 3D image would be acquired, with contouring of all organs used in
the planning process.

Finally, a treatment plan would be created for this specific

anatomical instance. A prospective virtual study has shown a theoretical increase to the
therapeutic ratio of 13%.8 This would account for interfractional organ displacement
and deformation, but not intrafractional motion.
For several reasons, online planning is not practical in reality.

The biggest

hindrance is the time necessary to image, contour, and replan. Each of these steps
usually requires its own specialist to complete. The physicist or therapist is responsible
for the imaging, the physician for the contouring, the dosimetrist for the planning, and
the physician and physicist for quality assurance (QA) checks. This workflow under the
time constraint of the patient on the table is not currently feasible. Current techniques,
such as those reported by Wu, involve modifying the workflow of online adaptive
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planning. In Wu’s method, a CBCT image of the patient in the treatment position is
acquired and DIR is performed to map this treatment image to the patient’s planning
image. The resultant transformation is then used to deform the dose distribution from
the original plan; the deformed dose becomes the “goal” of a new plan. Re-optimization
is performed in order to determine the fluence map that gives the goal dose.
reported the time needed for the optimization process to be 2 minutes.11

Wu
While

promising, this process is still quite lengthy, and the poor quality of CBCT images could
cause the DIR to give a suboptimal registration. Deterministic corrections are much
more practical, such as repositioning the patient to align the treatment isocenter. This
strategy still leaves some residual deformation of the organs unaccounted for,9,10 which
was investigated in this study. Thus, there is a need to create an initial plan robust
against anatomical uncertainties.
Probabilistic treatment planning (PTP) is the process by which one tries to
maximize the probability of specific treatment objectives in the face of a patient’s
unknown daily anatomy to ensure that the treatment objectives are met for a large
percentage of the daily anatomical realizations. These treatment objectives vary greatly
in complexity.

The simplest objective (and the one most commonly used) is an

expansion of the CTV by a margin to create the PTV, which ensures that most
anatomical deviations from the planning image will still be confined to this volume.
More advanced methods, such as coverage optimized planning first presented by
Gordon, incorporate the dose coverage probability in the face of organ motion directly
into the optimization process.56
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While both of these methods are built to withstand unknown day-to-day variations
in patient anatomy, both require knowledge of the uncertainty associated with the
patient’s underlying organ motion. For this reason, there is value in a patient-specific
model of anatomical deformations. A 3D statistical motion model of the patient allows
these probabilistic methods to create a plan robust against realistic organ motion as
opposed to the simplistic translational estimates currently used. The uncertainty in the
patient’s anatomy can be analyzed, and if there are certain deformations that are more
likely, this knowledge can be used to create a plan that is robust even with the
anatomical uncertainty.
In this chapter, patient-specific statistical motion models are created using
principal components analysis. The PCA technique has been used previously to model
the organs of the pelvis, most notably in the work of Sohn.46 In their work, PCA was
used to model the shapes of the prostate, bladder, and rectum. Four eigenmodes were
found to be sufficient to describe each of their four patient’s daily organ shapes to within
2 mm. While this work laid the framework for individual modeling using PCA, it was
limited in its applications. Their PCA models were limited to the organ shapes, ignoring
the daily anatomical changes within and outside of the three organs analyzed. In this
thesis, PCA will be used to develop models for all of the patient’s anatomy using DIR of
a series of fan-beam CT images.
2.1.1. Systematic and random errors
In this work, a patient-specific model was created by partitioning daily anatomical
differences into systematic and random components. These components are defined
and discussed in the context of what is define as “traditional radiotherapy” in this thesis.
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In traditional radiotherapy, a patient comes in for a pretreatment CT. This image is then
used to create a desirable treatment plan that is to be used for the entirety of the
patient’s treatment regimen.

Thus, this image is called the planning image.

This

planning image only represents one of the many possible anatomical instances of this
patient. In a worst-case scenario, this anatomy can represent an unlikely instance of
the patient’s possible anatomies, and thus introduce a systematic difference between
the dose intended to be delivered and the dose actually delivered. For this treatment
methodology, one hopes that the planning image represents the patient’s average
anatomy. In this work, systematic error was defined as the difference between the
patient’s planning anatomy and the patient’s mean anatomy, averaged over the course
of treatment. A simple 1D example of systematic error is shown graphically below in
Figure 1.
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Figure 1. 1D example of systematic error. The points represent the patient’s treatment isocenter
on each day, k. The blue line is the patient’s average treatment position over the course of
therapy. The orange line is the systematic error, or the difference between the planning isocenter
and the mean isocenter position.

Determining and planning on the patient’s mean anatomy does not eliminate
anatomical errors by itself. The daily fluctuations between the mean anatomy and the
daily anatomy will also alter the delivered dose distribution. These residual differences
are known as the patient’s random error. The sum of the systematic and random error
equal the displacement of the patient’s planning anatomy from the patient’s anatomy at
the time of treatment. Therefore, there is a single, constant systematic error for each
patient and a different random component for each treatment day. These errors are
defined more rigorously in the following sections.
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2.2.

Creating the patient-specific model
In this section, the patient dataset used throughout this thesis is outlined, as well

as an overview of the deformable image registration (DIR) algorithm used.

The

concepts of systematic and random error are mathematically defined, and a principal
component analysis technique is applied to the data to create a patient-specific 3D
statistical model.
2.2.1. Patient dataset
The patient dataset used in this thesis consisted of a set of serial anonymized fan
beam CT images, I i , k ( x ) , of the male pelvis for patients undergoing definitive EBRT for
prostate cancer. These images were obtained from the Netherlands Cancer Institute
(NKI), where I i , k ( x ) is the image intensity at voxel x of the CT of the ith patient acquired
at his kth fraction. Each of the N  19 patients ( i  1,  , N ) had planning (k=0) and

Pi  8, ,13 (median 11) fractional images ( k  1, , Pi ) acquired throughout the course
of treatment. There were 210 fractional images used in this study. On each of these
images, the prostate, bladder, and rectum were contoured by a single experienced
radiation oncologist. The images were initially rigidly aligned on bony anatomy. The
cutoff for the superior boundary of the rectum was the inferior edge of the iliosacral
joints. Patients were instructed to evacuate their bladder and rectum one hour prior to
treatment. Afterwards, they were told to drink 250 mL of water. The staging of the
patients and other details of treatment are given by Deurloo.57
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2.2.2. Deformable image registration
To quantify the differences between the anatomy of the day and the planning
anatomy, DIR was used. DIR is the process of determining the mapping of each voxel
in one image (the fixed image) to its corresponding location in another image (the
moving image). These mappings are represented by vectors anchored at the voxel
centers of the fixed image. These vectors “point” to the corresponding location in the
moving image.

For each patient in this dataset, the Eulerian transformation,

h i ,k  i ,0   xi ,0  , was defined as

h i ,k  i ,0   xi ,0   xi ,0  u i ,k  i ,0   xi ,0 

(1)

Here, u i ,k  i ,0   xi ,0  is the DVF that associated with h i ,k  i ,0   xi ,0  and x i ,0 is the
planning image coordinate system for the patient. The transformation maps the spatial
locations, x i ,0 in the patient’s planning image, I ( x i ,0 ) , to the corresponding location, x i , k ,
in his treatment position image, I ( x i , k ) .
In this work, the small deformation, inverse consistent, linear elastic (SICLE) DIR
algorithm was used in order to compute the transformation. Details about this algorithm
have been published.58 SICLE calculated the initial set of DVFs used in this work using
both grayscale and contour information. SICLE’s objective function contains intensity
matching, inverse consistency, and regularizing terms.

The intensity matching was

done by minimizing the sum of squares differences of CT intensities and contour
information. Contours were incorporated by converting each one to a binary mask
image. The optimization was simultaneously done on these binary mask images as well
as on the grayscale CT images. The contours used in these studies were the prostate,
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bladder, and rectum.

The algorithm simultaneously searches for both forward,

h i ,k  i ,0   xi ,0  , and inverse, g  i ,0  i ,k   xi ,k  , DVFs relating the two input images and their

associated contour masks. The objective function contained terms penalizing inverse
inconsistent registrations. Finally, a linear elastic regularizing term was also included in
the objective function. The transformation was parameterized using a Fourier basis,
with the Fourier basis coefficients representing the transform parameters being actively
optimized. The algorithm utilized a multi-resolution approach, first by minimizing the
objective function on a course image grid and then by iteratively refining the Fourier
coefficients on a finer resolution. The final DVFs spanned the whole image with voxel
sizes of approximately 1.8x1.8x0.3 mm.
2.2.3. Construction of the patient-specific PCA model
A patient-specific statistical model gives the magnitude, direction, and likelihood
of a given deformation between the patient’s anatomy at the time of planning and the
anatomy at the time of treatment. As each model described the organ motion for a
particular patient, one model was constructed to describe the anatomical motion of each
patient, i , in the dataset. To build the models, CT images from different days were
deformably registered to their planning image. As each daily image was registered to
the same planning image, each DVF shared the domain of the planning image, x i ,0 .
Together, the DVFs represented repeated measurements of how the anatomy in the
planning image moved from day to day. From these DVFs, a systematic error DVF
could be easily computed for the ith patient as

ui  xi ,0  

1 Pi
 xi,0 
u
Pi k 1 i ,k i ,0
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(2)

for patient i with PN fractional images. The random error component for each fraction
could then be found as the residual error after correcting for the systematic error
Δu  i , k  i ,0   x i ,0   u  i , k  i ,0   xi ,0   ui  xi ,0 

(3)

Since the systematic error was constant for the duration of treatment, an
individual patient deformation model, hereafter referred to as the individual model, was
based solely on random error displacement.

This work used principal component

analysis to create a patient’s individual model. For a more technical description of PCA,
please refer to Appendix A. The covariance matrix used as input to the PCA was
constructed as follows





Ci  cov Δui ,k i ,0  xi ,0  

T
1 Pi
Δui ,k i ,0  xi ,0   Δui,k i,0  xi ,0 

Pi k 1

(4)

PCA is the eigendecomposition of this covariance matrix, which determines the linearly
independent orthonormal eigenvectors, v i ,l , and eigenvalues, i ,l , that satisfy the
following equation

Ci vi ,l  i ,l vi ,l

(5)

The eigenvalues represented the fraction of the variability in the data
corresponding to its associated eigenvector. The eigenvalues were sorted, with the
largest one associated with the most principal component, v i ,1 , the second highest with
the second most principal component, v i ,2 , and so forth. The first L eigenvectors were
kept. The principal components formed an orthogonal basis, which could be used to
reconstruct the original SICLE DVF
L

u  i ,k  i ,0   xi ,0    ci ,l v i ,l  ui  xi ,0 
l 1
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(6)

where ci ,l were scaling coefficients calculated by
ci ,l  Δu  i , k  i ,0   x i ,0  v i ,l

(7)

2.2.4. Kernel density estimation
The eigenvectors resulting from the PCA were linearly independent of one
another. This means that the probability of a given deformation was the same as the
probability of randomly sampling the associated set of expansion coefficients to be used
in conjunction with equation (24) in Appendix A.

Selecting appropriate expansion

coefficients maintained the spatial correlation between the voxels while possibly
reducing the dimensionality, if certain eigenvectors added little to describing the
variance in the data. For these reasons, it was desirable to be able to randomly sample
these expansion coefficients from a probability density function (PDF). Following the
method of Murphy et al.,59 the calculation of these PDFs was determined using kernel
density estimation (KDE), also called Parzen windowing.60,61 In the end, there was one
PDF associated with each eigenvector.
Practically, this was done by creating a histogram of the training coefficients, cik,l ,
associated with each eigenvector, l  1 Li . In order to represent 100% of the variance
in the daily deformations, L  Pi  1 .

The training coefficients were the expansion

coefficients needed to represent the SICLE generated DVFs as a linear combination of
the eigenmodes, vi,l . Each of the daily random errors could be reconstructed using the
patient’s systematic error, a set of Li eigenvectors, and their associated expansion
coefficients. The coefficients were calculated using equation (25) in Appendix A.
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The expansion coefficients were found for each fractional DVF and eigenmode, l ,
creating a matrix of coefficients for each patient, i .
 ci1,1

 
ci   ci1,l

 
c1
 i , Li

 cik,1
 
 cik,l
 
 cik, Li

 ciP,1i 

  
 ciP,il 

  
 ciP,iLi 

(8)

The columns of the coefficient matrix, ci , represent the coefficients needed to
reconstruct the fractional DVFs. The rows represent the coefficients corresponding to a
particular eigenmode.
PDFs were calculated for each eigenmode, each using the coefficients in the
corresponding row of ci . In this study, a continuous Gaussian kernel was used for the
KDE, which centered a Gaussian around each coefficient for a given eigenmode. The
resultant PDF was then constructed as the superposition of these Gaussians. The
mathematical formulation is given in Equation (9) for the l th eigenvector
   c  c k 2
i ,l
pi ,l  c  
exp 

2
2

2b
Pi 2 b k 1

1

Pi






(9)

where b is a user-adjustable bandwidth parameter. This parameter adjusts the width of
the Gaussian kernel used. In this work, the parameter was calculated from a heuristic
rule of thumb put forth by Silverman62:

  SD

b  1.06 N

1
5
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data

(10)

where SDdata is the standard deviation of the training coefficients ( ci1,l - ciP,il ) associated
with a particular eigenmode, l . Using this method, one PDF was generated for each of
the Li principal components.
2.2.5. Sampling coefficients from the KDE-generated PDFs
For patient-specific random error uncertainty, sampling the expansion coefficient
PDFs allowed for the creation of “synthetic DVFs,” u  i ,syn  i ,0   x i ,0  , by inserting sampled
coefficients, cisyn
,l , into the following equation:
Li

u  i ,syn  i ,0  x i ,0    cisyn
,l v i ,l  u i  x i ,0 

(11)

l 1

The synthetic DVFs were statistically consistent with those in the training set,
meaning that there should have been no significant difference in the spread of the
training set vectors and the corresponding synthetic ones. To sample each PDF, a
rejection sampling technique was implemented in this research. The tails of the PDFs
were nonzero and extended to infinity. Because of this range, the tails were cut off to
improve the sampling efficiency. The cutoff was made to meet the requirement that the
function at this point was at least 0.0001 of the maximum value.
2.2.6. Evaluation of the patient-specific PCA model
As an initial evaluation of the patient-specific model, the original SICLE DVFs
were reconstructed as linear combinations of eigenmodes and expansion coefficients.
More rigorously, the statistical correlation of synthetic DVFs output from the patientspecific PCA model with the training DVFs were confirmed. Specifically, in this section I
compare the distribution of voxel vectors in the training set to those synthetically
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created.

Hypothesis testing was performed to determine any significant difference

between the distributions.
2.2.6.1. Evaluation of the patient-specific PCA model’s ability to reconstruct
training DVFs
PCA allows one to represent the original SICLE DVFs, u i ,k  i ,0   xi ,0  , as a linear
combination of eigenmodes and scalar expansion coefficients. If no eigenmodes are
discarded ( Li  Pi  1 ), the PCA model should reconstruct the training data perfectly
using equations (6) and (7).

This is the simplest check that the eigenvectors and

expansion coefficients are being calculated correctly.

Performing this test with all

fractional DVFs for all patients, PCA was able to reconstruct each DVF perfectly.
2.2.6.2. Direct evaluation of individual model on voxel vectors
The evaluation above indicates that the individual patient statistical PCA method
was correctly calculating the eigenvectors and expansion coefficients. This check, while
important, does not test the KDE or PDF sampling of the PDFs. The general flow of the
evaluation used to check the entire modeling process is given in Figure 2. In this
methodology, 1000 synthetic DVFs were created using equation (11). At this point, the
1000 vector values were extracted from each voxel located within the prostate, bladder,
and rectum contours as defined on the planning image.

The 11-13 corresponding

vector values from these same voxels were then extracted from the original SICLE
calculated DVFs. Finally, differences in the distributions of the synthetic and calculated
vector values were tested against the null hypothesis (p<0.05 criteria used) at each
organ occupied voxel. The Wilcoxon rank-sum test was used for the hypothesis testing.
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Read in eigenvectors, systematic
displacement, and sampled
coefficients

Create a synthetic DVF "on the fly" by
linear combination of eigenvectors
and randomly sampled coeffiecients

n=n+1

Extract vectors from voxels within the
prostate, bladder, and rectum

No
n=1000?

Yes
Voxel by voxel comparison between
distribution of synthetic vector values
and measured vector values

Finish

Figure 2: Flowchart for the evaluation of the individual PCA model. This flowchart was used for
all patients; it extracted the vector values at voxels within the organs of interest (prostate,
bladder, and rectum) to be compared with those of those in the SICLE generated DVFs.

For all patients, there were no significant differences in the vector distributions for
any voxels within each patient’s planning regions of interest. A histogram of all of the
p-values for all voxels in the patient population is given in Figure 3. This result was to
be expected, as the PCA model was designed to recreate the distributions of the data
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used in the input. Although the PCA model has the ability to create unique synthetic
deformations, these deformations are probabilistically tied to the distribution of the
underlying measured data.

Figure 3: Histogram of p-values from hypothesis testing (Wilcoxon rank-sum test) of the synthetic
and true voxel vector distributions. No differences were found to be significant, with the minimum
p-value equal to 0.36.

For illustrative purposes, the displacement for a single voxel (located centrally
within the prostate) was investigated in one patient. The voxel center (in x i ,0 ) was
displaced with the SICLE DVFs, u i ,k  i ,0   xi ,0  , creating a distribution of points. These
points are the locations of that piece of tissue on each training image. The voxel center
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in the planning image was similarly displaced with 1000 synthetically sampled DVFs,
u  i ,syn  i ,0   x i ,0  , from the individual PCA model, creating its own distribution of locations

of this voxel. A 3D scatter plot of the displaced voxel location is shown in Figure 4.
Assuming the individual PCA model was correctly implemented, these two distributions
should be identical.

The distribution means and standard deviations of the two

distributions, as well as the p-values, are given in Table 2.

The results show no

significant differences in the distributions.

Figure 4: 3D distribution of a central prostate point location after being displaced with the training
SICLE DVFs (red) and sampled synthetic DVFs (blue). This was done for a single sample patient.
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Table 2: The mean and standard deviations of deformed central prostate location (cm) in the LR
(left-right), AP (anterior-posterior), and SI (superior-inferior) directions for the SICLE DVFs
(measured data) and the synthetically sampled DVFs (synthetic data). The p-value calculated from
a Wilcoxon rank-sum test is also given between the two distributions.

Prostate

LR

AP

SI

23.32

23.69

14.14

0.11

0.26

0.11

23.32

23.69

14.14

Standard Deviation (cm)

0.12

0.28

0.13

p-value

0.99

0.97

0.86

Average Position (cm)
Measured Data
Standard Deviation (cm)
Average Position (cm)
Synthetic Data
Hypothesis
Testing Between
Distributions

These tests demonstrated the individual model’s ability to create many synthetic
deformations taken from a distribution probabilistically tied to that of the original training
DVFs. These results give confidence that the KDE method implemented in this work
created meaningful PDFs for sampling coefficients.

With these tools in hand, the

problem of sampling synthetic deformations probabilistically tied to the training data can
be reduced to sampling a set of expansion coefficients from their associated PDFs to be
incorporated into equation (11).
However, there are limitations to these tests. The analysis above only checks
the ability to create synthetic DVFs consistent with the measured DVFs input into the
PCA.

This does not test PCA’s ability to correctly predict the statistics of tissue

deformation for an individual not included in the original training set.

Although the

model represents the training data, there is no check that the set of training data
samples was sufficiently large enough to represent the underlying distribution of organ
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motion. Ideally, a study to test this would be designed as follows. First, a PCA model
would be created using the methods described above from a set of DVFs mapping a
patient’s fractional anatomy to his planning anatomy. This model would then be tested
on its ability to represent DVFs not included in the PCA training set. The expansion
coefficients would be calculated using equation (7), at which point they would be
inserted into equation (11) to calculate the PCA model approximation of the non-training
set DVFs. How well the model estimates the non-training set DVFs is a measure of
how robust the model is in representing the patient’s organ motion. This more complete
validation was not possible in the current work, as it required larger amounts of data
than were available.
2.2.7. Potential applications
2.2.7.1. Virtual clinical trials (VCTs)
The patient-specific PCA model has the potential to be a useful tool when
performing VCTs. A VCT is a framework for testing a clinical hypothesis using virtual
patient data and theoretical outcome (bio-effective) models instead of actual patients
and clinically observed rates of control and toxicities. This is quite useful in radiation
therapy. Different planning and delivery techniques can be simulated in a treatment
planning system (TPS) on the patient’s planning image. The resultant fluence maps
can then used to calculate the daily dose deposition, given the patient’s different daily
anatomies (daily images). DVFs are used to deform the dose to the planning image,
where the total dose over the course of treatment can be accumulated on a voxel-byvoxel basis. The resultant dose distributions from the various planning techniques can
then be directly compared. This is generally done with a temporal sequence of CT
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images simulating the patient’s anatomy on a given treatment day. In practice, it is not
common to give a patient enough CT scans to simulate an entire fractionation
treatment. This is where the PCA model might be of some benefit.
Using a limited number of patient CT images with their resultant DVFs mapped to
the planning image, the PCA model can synthetically create an infinite number of
unique deformations that are statistically correlated to the input DVFs. There are two
main benefits for doing this. First, an entire fractionation scheme of synthetic anatomies
can be created using a smaller number of input images. This is done by deforming the
planning CT with the inverse of the synthetic DVFs generated with the PCA model. This
provides

the

experimenter

with

numerous

daily

anatomies

and

their

exact

corresponding DVFs, relating the daily image to the planning image. Using the known
DVF, contours can easily and accurately be propagated onto the image of the day.
Also, the synthetic DVF can be used to accumulate dose over a fractionated treatment.
Using the simulated forward and inverse synthetic DVFs to create the virtual data
eliminates any registration errors that would occur by using an imperfect deformable
image registration algorithm on “real” daily images. Example synthetic geometries are
given in Figure 5.
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Axial

Sagittal

Figure 5: Axial and Sagittal views of three different synthetic geometries for a single patient
created using the individual PCA model.

There are some limitations to the PCA model approach to VCTs. The first is that
the resultant synthetic DVFs are only as good as the underlying data used as input to
the PCA. If there is some component of a patient’s anatomical variation that is not
42

present in the training data, this component will also be absent from any PCA model
derivative anatomy. It is therefore important to utilize an adequate number of input
DVFs in order to model the full variability of organ motion in that patient. For this
reason, it is also important to use the best possible DVFs as input to the PCA. This
study used DVFs that were generated using both grayscale matching and manually
drawn contour coincidence to drive the registration. The rationale was to use as much
a priori knowledge as possible to get the most accurate transformation possible
describing the deformation.
Another limitation to using the PCA model is the inability to create wildly different
anatomies. All synthetic anatomies are created by deforming the patient’s planning
image with a known DVF. Because of this, only features present in the planning image
will be present in the synthetic image.

For example, if the planning image had

contained a large gas pocket in the rectum, this feature would be present in all synthetic
images created by way of the PCA model. The gas pocket may expand or shrink, but it
will never go away completely. This is not the reality, as the presence of bowel gas in
patients routinely changes day-to-day. This problem could be addressed by deforming
the different daily images to the planning image coordinate system, creating a set of
planning image-like images.

These images would maintain the basic anatomical

positions, but with varying amounts of bowel gas.
2.2.7.2. Individual model as input to probabilistic planning
This PCA model potentially holds some value when used in conjunction with
PTP. All PTP methods designed to account for interfractional motion need an estimate
of the distribution of the potential daily errors. The PTP algorithm can only account for
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organ motion described in its underlying measure of the patient’s anatomical
uncertainty. It is here that the PCA model described above would be of benefit.
One such PTP algorithm in which the individual PCA modeling has been
incorporated is in coverage optimized planning (COP), as first proposed by Gordon et
al.56 The aim of COP is to build a plan robust to anatomical uncertainty using coverage
probability. This creates a plan where there is a high (i.e., >95%) probability that a
structure will be covered by certain dosimetric criteria on any given day. COP uses the
concept of the dose coverage histogram, which is a cumulative distribution of all
possible voxel doses in the presence of geometric uncertainties. COP then optimizes
on the dose coverage histogram, choosing a plan with a high probability (i.e. 95%) of
delivering a given cumulative dose to the patient over the whole course of treatment. In
the initial proof-of-concept paper, a rigid prostate was assumed, with the standard
deviation of the distribution of systematic and random errors set to 3 mm. A shift was
determined as the sum of two samples taken from the systematic and random normal
distributions. These shifts were used to calculate the coverage probability, completely
ignoring deformation.
To expand this concept, the work presented in this thesis was coupled with the
research being done with COP.

Instead of rigidly translating the prostate by an

estimated normal distribution, the PCA model was used to create a more realistic
patient model for the coverage probability calculation. Thus, fully 3D deformations of
the patient’s anatomy were taken into account when optimizing the plan. This work, of
which the author of this thesis was a coauthor, was led by Xu and is described in a
paper published in Medical Physics.63 In this paper, the individual model described
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above was used to create the virtual dataset of synthetic anatomies needed to compare
COP technique (CPCOP) to two other planning techniques. One planning technique
created a plan utilizing a fixed, 5 mm uniform margin (FM) and the other utilizing an
optimized uniform margin (CPOM).

The optimized margin was the uniform margin

needed to ensure that the D98 was greater than or equal to the prescription dose with
95% coverage probability (D98,95).

Utilizing the same prostate patient cohort, Xu

compared the plans using dose coverage criteria as well as complication-free tumor
control probability (P+). In the plans, the prostate prescription dose was 78 Gy, with the
seminal vesicles prescription being 66 Gy. The two dose limiting structures were the
bladder and the rectum, with an artificial ring structure used for IMRT optimization. The
results are summarized below; the reader is referred to the paper for the details of
planning and a full analysis of the results.
Of the three plans, CPCOP was favored in 7/19 patients, while CPOM was favored
in 12/19 patients, with the advantages of each plan being patient specific. The patientby-patient advantages are given in Table 3, taken from Xu’s paper with permission.
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Table 3: Patient study ID, the preferred planning technique and the most representative gain with
respect to the other two plans in terms of target dose D98,95 for the prostate CTV (CTVprostate)
or the seminal vesicles CTV (CTVSV), normal tissue coverage Dv,5 for bladder or rectum, and
probability of complication free control P+. ID with */ † / ‡ denotes CPCOP / CPOM / FM plan that
fails to achieve target D98,95.
ID

Best Plan

Gain Relative to the Other Plans

1*

CPOM

CPCOP (+0.8% CTVprostate D98,95)

FM (+6.5% P+)

2*†‡

CPOM

CPCOP (+4.0% CTVprostate D98,95)

FM (+1.3% CTVprostate D98,95)

3*

CPOM

CPCOP (+3.4% CTVprostate D98,95)

FM (+2.8% P+)

4*‡

CPOM

CPCOP (+7.3% CTVSV D98,95)

FM (+1.0% CTVprostate D98,95)

5*

CPOM

CPCOP (+7.2% CTVSV D98,95)

FM (+11.9% P+)

6*

CPOM

CPCOP (+1.0% CTVprostate D98,95)

FM (+21.5% P+)

7

CPCOP

CPOM (-3.2% Rectum, D2,5)

FM (+4.2% P+)

8*

CPOM

CPCOP (+9.8% CTVSV D98,95)

FM (+0.9% P+)

9*†‡

CPOM

CPCOP (+7.3% CTVSV D98,95)

FM (+5.0% CTVSV D98,95)

10*†‡

CPCOP

CPOM (+1.2% CTVSV D98,95)

FM (+5.5% CTVSV D98,95)

11‡

CPCOP

CPOM (+5.9% P+)

FM (+1.1% CTVprostate D98,95)

12†‡

CPCOP

CPOM (+0.8% CTVprostate D98,95)

FM (+2.4% CTVprostate D98,95)

13

CPOM

CPCOP (+2% P+)

FM (+3.1% P+)

14

CPOM

CPCOP (-3.1% Rectum, D2,5)

FM (+3.3% P+)

15*

CPOM

CPCOP (+8.8% D98,95)

FM (+22.8% P+)

16‡

CPCOP

CPOM (+1.7% P+)

FM (+1.0% CTVprostate D98,95)

17*

CPOM

CPCOP (+3.9% CTVSV D98,95)

FM (+9.5% P+)

18*†‡

CPCOP

CPOM (+0.6% CTVprostate D98,95)

FM ((+0.8% CTVprostate D98,95)

19

CPCOP

CPOM (-0.6% Rectum D30,5)

FM (+6.4% P+)

Table reprinted from Xu with permission.

2.2.7.3. Individual PCA model as input to adaptive planning
The patient-specific PCA model has potential application to IGART. Without a
sufficient number of images, it is impossible to characterize sufficiently the patient’s
anatomical motion. Thus, it is impossible to utilize this statistical model before that
patient starts treatment. However, in-room daily patient imaging (such as CBCT) is now
commonly used for patient setup and verification.

These images may be collected

during the first several, usually 5, treatment fractions. A Beaumont-style ART method
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could be implemented by building the patient’s individual PCA model offline using these
initial 5 daily CTs. The PCA model could then be used to create an adaptive plan to be
delivered for future treatments. This could be done once, or continually throughout
treatment, as more information about the patient’s anatomical motion becomes
available.
Future research is needed to test the feasibility of this method for the PCA
model. There are several unknowns and complicating factors that would have to be
resolved before this is deemed a viable option. First, CBCT images are of substantially
worse quality when compared to the fan-beam CT images used in the planning process.
This lack of image quality makes the initial registrations difficult. Secondly, the number
of images needed to estimate adequately the patient specific organ motion distribution
requires investigation. Using too few images could cause the PCA to miss some modes
of motion completely. Beaumont ART uses Kalman filtering to account for the residual
uncertainty from using a limited number of daily images. A similar method could be
implemented for the patient-specific PCA model.
2.3.

Conclusion
In this chapter, a methodology was described for creating a patient-specific

statistical model of day-to-day random anatomical deformations. Such models were
built for all 19 patients in the dataset, and each model was validated by comparing the
distribution of the vectors in the initial dataset to synthetically created vectors. These
models have potential applications in virtual clinical trials, probabilistic treatment
planning, and image guided adaptive radiation therapy.
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3.

3.1.

Population PCA modeling of systematic and random tissue
displacement errors in prostate cancer

Introduction
In general, a patient-specific statistical model of anatomical motion is not

possible before the start of treatment. Several days’ worth of images are required to
create a model that can accurately describe the magnitude and likelihood of the
patient’s organ motion, when conventionally there is only a single planning image taken
before treatment. In this scenario, a population statistical model, such as one created
using PCA, could prove beneficial. A population model could determine the magnitude
and likelihood of systematic and random deformations across a patient population. A
population model also has the potential to model residual systematic and random errors
that remain after a deterministic correction (i.e. aligning to fiducial markers or organ
centroid).

Currently, these residual uncertainties remain unaccounted for.

This

knowledge can be directly incorporated into the planning process by determining the
probability of an organ of interest occupying a given volume in the patient’s planning
image.
PCA has previously been applied to the population modeling problem in the work
of Budiarto et al.49 In their paper, they created a population shape model of prostate
and seminal vesicle random displacement. With an 18 patient data set used to build the
model, they were able to reconstruct the prostate/seminal vesicle shape of three
patients not included in their training set to within 1.5 mm. This work only modeled the
shape of these two organs, and did not take into account the complex motions of any
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surrounding anatomy, including the bladder and rectum. Also, the work of Budiarto
ignored any systematic displacements. The work in this thesis expands on this previous
work by including both systematic and random displacement population modeling for
the three organ system of the prostate, bladder, and rectum.
Population modeling is associated with a new set of challenges when compared
to individual modeling. As described earlier, each patient has a single systematic error,
which relates the patient’s planning anatomy to the patient’s mean anatomy. Each
patient’s systematic error is unique and cannot be computed before treatment. Thus, a
population model of systematic tissue displacement must account for the distribution of
all possible systematic errors. A similar distribution of random errors can be created
across the patient population to form a population model of random tissue
displacement. Both systematic and random error distributions should be considered
when incorporating such modeling into the patient planning.
A reference coordinate system is needed in the formulation of both systematic
and

random

error

population

models.

Generally,

PCA

requires

numerous

measurements of a set of variables. The measurements used in this thesis are the
displacement vectors “anchored” at the voxel centers of the reference image.

The

reference image used in the individual model was the patient’s planning image.
However, each patient’s planning image had a unique coordinate system, which
represents a problem when trying to pool systematic and random errors from different
patients.

In this chapter, I propose a solution to this problem: transporting each

patient’s individual systematic and random errors to a calculated reference anatomy.
This is accomplished through the use of interpatient DIR.

49

With each patient’s individual statistics transported to the reference coordinate
system, the concept of  and  (as described previously) can be extended from the
traditional 1D formulation to 3D for both bony- and prostate centroid-aligned patient
setups. PCA models for both systematic and random organ motion can be created in a
similar fashion to the models described in Chapter 2. The detailed creation of these
models and their validation is included in a manuscript to be submitted to Medical
Physics, attached in Appendix B. This chapter summarizes the work reported in this
manuscript, referring to the Appendix for the details and specific results.
3.2.

Construction of a reference image using interpatient DIR
In order to determine any common modes of systematic or random tissue motion

in a population of patients, a common coordinate system is needed. This is achieved by
determining the transformation, h i ,0ref  xref  that maps each patient’s planning image,
I  x i ,0  , to a reference image, I ref  xref  .

This registration can be used to transport

patient-specific systematic and random errors into the reference coordinate system,
x ref .

Determining the interpatient transformations is a challenging task, as the

anatomies in the two images being registered vary greatly. Straightforward application
of SICLE, as described in the previous chapter, failed to converge to a solution. As a
result, the prostate, bladder, and rectum were registered separately using contour-only
driven registrations.
The construction of I ref  xref  was done by registering each patient’s planning
image to a preselected patient’s planning image using the organ-by-organ registrations.
This preselected patient was chosen for its lack of abnormal anatomy (such as minimal
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bowel gas, artifacts, average organ sizes) upon visual inspection. The resultant organspecific DVFs were then averaged to determine the mean organ DVFs. Next, the mean
DVFs were used to deform their associated organ in the preselected patient’s planning
anatomy to the mean organ shape across the patient population. These shapes were
then stitched together to form the reference image, I ref  xref  , which was limited to the
three pelvic organs. At this point, each of the patient’s planning images was registered
to I ref  xref  on an organ-by-organ basis, giving the transformations hbladder
 i ,0ref  x ref  ,
prostate
hprostate
x , and hrectum
x , along with their inverses g bladder
i ,0 ref  ref 
i ,0 ref  ref 
 i ,0  ref  x i ,0  , g  i ,0  ref  x i ,0  ,

and g rectum
x .
i ,0  ref  i ,0 

3.3.

Transporting patient-specific statistics to the reference coordinate system
The patient-specific systematic ( ui  xi ,0  ) and random ( Δu  i , k  i ,0   x i ,0  ) errors

were then transported into the reference coordinate system. This was done by treating
the systematic and random errors as vector-valued images and deforming them using
prostate
rectum
each of the transformations, hbladder
 i ,0ref  x ref  , h i ,0ref  x ref  , and h i ,0ref  x ref  . To form a
, ref
single systematic, uiunion , ref  x ref  , or random, Δu union
 x ref  , error in the reference
i, j

coordinate system, the resultant organ-specific motion errors were stitched together
using equations (5) and (6) in Appendix B. This was done for two different patient
setups, a bony-aligned setup and a prostate centroid-aligned setup. Practically, the
difference between the two setups was the initial alignment of the patient planning and
fractional images.
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3.4.

Inverse consistency error
The common coordinate system requires individual statistics from each patient to

be mapped to the reference image.

However, for the model to be of any value,

information gained in the reference coordinates must be mapped back to a patient’s
local coordinate system. Any inverse inconsistency in the interpatient transformations
mapping to and from the reference frame will introduce an “inverse consistency error.”
To quantify this, patient-specific systematic and random errors were mapped to the
reference frame, and then immediately back to the patient’s local coordinate system and
compared with the original.

The mean and standard deviations are reported in

Appendix B (Figure 2 and Table 1). In each organ for all patients, the mean inverse
consistency error is less than 0.2 mm, with over 99%, 98%, and 92% of the voxel-byvoxel inverse consistency errors less than 0.3 mm for the prostate, bladder, and rectum,
respectively.
3.5.

Quantifying systematic and random error distributions for the population
With each patient’s individual statistics successfully transferred to the reference

coordinate system, a statistical characterization of patient population was derived. This
was done by expanding the concepts of group mean, M , systematic (  ) and random (
 ) error distributions to three dimensions.

These concepts were originally used to

describe the organ motion and setup error at a single point (prostate centroid), which
was taken as a surrogate for the entire prostate. The three-dimensional formulations
are given in Appendix B equations (8)-(10). Maps of these values for the two prostate
centroid and bony patient setups are given in Appendix B (Figure 3 and Figure 4). The
results are as expected, with the bony aligned  and  values being smaller near bony
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edges and a centroid-aligned setup showing smaller  and  in the central portion of
the prostate.
3.6. Population PCA modeling of systematic and random tissue displacement
errors
PCA modeling was performed separately for systematic and random errors, as
well for the two different patient setups. The PCA formalism for this scenario is given in
Section II.F. of Appendix B and is done in the same manner described in the previous
chapter. The two covariance matrices used for the systematic and random errors are of
particular importance, given below.

Csys 
C rand 

1
Dsys D sys
N 1



1
N

P
i 1





T

D rand D rand

(12)



T

(13)

i

where D sys and D rand are the mean subtracted data matrices of the population of
systematic and random errors, respectively.

In total, the systematic PCA model is

calculated from 19 systematic errors while the random PCA model is created from 210
random errors.
3.7.

PCA modeling error
Unlike in the previous chapter, not all eigenvectors were used in the modeling. In

both the systematic and random population PCA models, only the eigenvectors needed
to represent 95% of the variance were kept. Eleven and 33 eigenmodes were needed
for the systematic and random population models, respectively, to represent 95% of the
variance in the data. Discarding some eigenmodes introduced error in reconstructing
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the original set of systematic and random errors. To quantify this “PCA modeling error,”
the difference was computed between the original systematic and random errors and
those reconstructed using the limited number of eigenvectors. For systematic error, the
voxel-by-voxel differences were calculated for each organ, with 96% of all organ voxels
having modeling error less than 1 mm.

The patient-by-patient results for both

systematic and random error are given in Figure 65 of Appendix B.
3.8.

Leave-one-out study
The PCA models created in this chapter are only useful if they can accurately

describe the systematic and random errors of patients not part of the original training
set. To test this, a leave-one-out study was conducted, where 19 different systematic
and random error PCA models were created, each one using data from only 18
patients. Each model was then used to reconstruct the systematic and random errors
from the “left out” patient. Within each organ, the voxel-by-voxel differences between
the reconstructed systematic and random errors were calculated, with the mean and
standard deviations of these differences reported. The mean voxel differences were all
near zero, but the standard deviations were on the order of several millimeters for some
patients, as shown in Appendix B, Figure 76. For the patient population, the mean,
absolute mean, and standard deviations of the modeling errors in the leave-one-out
study are given in Appendix B, Table 3. The leave-one-out errors were larger for the
systematic population PCA model, suggesting a larger dataset may be necessary to
describe adequately the systematic anatomical motion in prostate cancer patients.
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3.9.

Organ occupancy maps
A straightforward and useful application of the population systematic and random

PCA models is in the construction of organ occupancy maps, which give the probability
of an organ occupying a certain voxel on any given treatment day. To do this, synthetic
systematic and random errors must be sampled from their respective PCA models. The
sampling was done using the technique outlined in the previous chapter, with KDE used
to construct the PDFs for each eigenmode. In this work, the sampled systematic errors
were added to the sampled random errors to produced synthetic deformations. These
deformations were then used to deform the reference anatomy, representing possible
instances of the treatment day anatomies. Each voxel was marked with a 1 if it was
within the synthetic anatomy, and marked with a 0 otherwise, creating a binary image.
This process was performed 1000 times, with the binary images averaged to yield
probability of the organ occupying a given voxel on a given day. This was done for both
bony- and centroid-aligned setups, and the results are given in Appendix B, Figure 87.
The centroid alignment has greater certainty in prostate localization when compared
with bony-aligned setup.
3.10. Discussion
This chapter outlines the creation of fully 3D population models of systematic and
random organ motion in prostate cancer patients. Patient-specific data was transported
to the reference frame via interpatient DIR. These interpatient registrations were a
difficult task; large discrepancies in patient anatomies caused the SICLE algorithm to
fail in instances where the whole CT image was used. Alternatively, this work used a
method where each organ was registered separately using contour information only.
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Although this approach was feasible for the prostate, bladder, and rectum, other pelvic
structures of interest such as the pelvic lymph nodes and seminal vesicles were not
modeled in this work.

Using a contour-only registration also made the modeling

dependent on SICLE’s regularization (linear-elastic constituitive law). For this reason, it
is possible a finite-element DIR algorithm would have been better suited to this work, as
it can produced non-diffeomorphic DVFs with support limited to the specified organs.
For the population modeling described in this chapter and its associated
appendix, interpatient registrations were used to directly deform systematic and random
displacement vector fields to and from the reference coordinate system. This method,
as used in this work, only represents an approximation of the true vector transport. As
the systematic and random displacement vectors are transported between the reference
and patient planning images, the orientation and magnitude of these vectors must
change as a function of the transformation from the reference to the new image space.
Mapping vectors from the reference to the planning images should have been done
using the pushforward, or differential of the interpatient transformation.
pushforward of the transformation h i ,0ref

is denoted by dh  i ,0  ref

The

and is a

transformation from R 3  R 3 . The pushforward is a linear map from the tangent space
in the patient’s planning image to the tangent space in the reference image, and is
computed as the Jacobian of h i ,0 ref . In this thesis, the pushforward was ignored.
Large differences in the results presented in this thesis due to this omission are not
expected to be substantial, as the organ shapes, even between patients, did not vary
greatly. In all future work, the pushforward will be utilized to transform the systematic
and random vectors.
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The population models created in this chapter have several possible clinical
applications. One apparent application is their potential use in PTP. The work of Xu63
simulated random organ motion, but assumed a known patient-specific systematic error
for each patient in their implementation of COP. This work could be extended to include
simulated systematic error as well, as each patient’s systematic error is unknown before
treatment.
A more straightforward application of the PCA population models to patient
planning is described in the following chapter. This method involves using the organ
occupancy maps calculated above to create anisotropic PTVs. The organ occupancy
maps can be thresholded to ensure a certain level (for example, 95%) of target
coverage. The dosimetric impact of planning on the PCA-based PTVs for bony- and
centroid-aligned patients will be the focus of the next chapter.
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4.

4.1.

Clinical application of a population statistical model of
prostate cancer anatomical motion

Introduction
The previous chapter centered on the creation and validation of systematic and

random tissue deformation PCA statistical models for a population of male pelvic
patients.

In this chapter, the systematic and random tissue deformation statistical

models will be referred to jointly as the “population PCA model.” The ultimate value of
any such model is its ability to deliver a better radiation therapy plan to the patient. In
this context, a better plan is one that is more likely to improve tumor control and/or
reduce normal tissue toxicity when compared to the current standard of practice. In this
work, physical doses to the CTV and OARs were used as surrogates for these
outcomes. There are numerous ways to apply the population PCA model clinically.
One of the more intriguing possibilities is to incorporate it into probabilistic planning.
Probabilistic planning could theoretically incorporate the geometrical uncertainty as
quantified by the PCA model directly into the optimization process. The goal would be
to find the optimal plan to best safeguard against dosimetric errors introduced by the
deforming anatomy.
In this study, a simpler clinical application of the population PCA model was
tested. The model was used to create “smarter” margins around a patient’s prostate, as
contoured on the planning image. These margins were calculated from the model by
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determining the magnitude, direction, and likelihood of a given prostate deformation.
These margins have the ability to be anisotropic, meaning that the thickness can vary
as a function of location on the prostate. This allows for a more liberal margin in areas
where a high magnitude of deformation is likely and a more conservative one in areas
where deformation is less likely.
This population PCA model-generated PTV was compared to a pseudo-uniform
margin, which is typically used currently in prostate treatments. The comparison was
done using the VCT framework.

Two plans created from two different PTVs were

applied to the daily anatomies of an entire fractionation scheme. The hypothesis was
that using anisotropic margins derived from the population PCA model would provide,
on average, plans with an improved therapeutic ratio compared to the current standard
of treatment. Information from the model regarding the deformations of the bladder and
rectum was not used in the planning process.
4.2.

Methods and materials

4.2.1. Planning data
The dataset used in this study was synthetically derived from the individual PCA
model, as described in Chapter 2.

For each of the 19 NKI patients described

previously, the DVFs mapping the fractional images to the planning images were used
to create an individual PCA model. Forty-three synthetic deformations were sampled
from each model, representing unique anatomies for an entire radiation fractionation
regimen. The resultant DVFs were then used to deform the patient’s planning contours,
creating a sequence of 43 synthetic prostate, bladder, and the rectal anatomies.
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Together, these 43 synthetic anatomies represented the patient’s daily anatomies over
a whole therapy course.
4.2.2. VCT subtrials
The VCT in this project had two subtrials, each comparing two arms. The two
arms of each subtrial comprised two setup strategies: an online bony-alignment IGRT
technique and an online prostate centroid-alignment IGRT technique. The centroidalignment method is similar to the online procedure presented by Smitsmans, in which
the prostate rigid alignment to the planning prostate anatomy is computed from the
grayscale values of daily CBCTs.64,65

For each setup strategy, two arms were

compared: a plan using population PCA model-based anisotropic margin and a plan
using a current standard planning technique. The first subtrial tested a bony-aligned
bone
population PCA model-based PTV ( PTVPCA
) against a PTV created using the van Herk

margin recipe ( PTVvH ). The second subtrial tested a centroid-aligned population PCA
cent
) against a PTV ( PTVcl ) created with the margin used in our
model-based PTV ( PTVPCA

clinic at VCU. For each subtrial and arm, an IMRT plan was created using the patient’s
planning image.

The planning image was a real patient (not synthetically derived)

image, with physician-drawn contours. Dose invariance was assumed, meaning the
dose distribution in the accelerator coordinate system for a given fluence profile does
not vary with changes in the patient’s anatomy.66 This assumption greatly speeds up
the computation time needed for the VCT, as the dose distribution calculated on the
planning image was overlaid on each daily synthetic geometry. This assumption has
been shown to introduce dose calculation errors of <2% in IMRT plans.66 The dose was
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then accumulated on the planning image using the known, synthetically sampled DVFs.
DVH metrics were calculated for each patient’s synthetic treatment course, and these
were averaged over all patients.
The second arm for each subtrial will hereafter be referred to as the “traditional
plan.” The PTV for these plans was taken by using a semi-uniform margin to expand
the physician-drawn planning GTV (which is taken to be the prostate only). The margin
for these plans was calculated differently for the two subtrials, each described in detail
below. The differences between the two are fully described in Appendix B.
4.2.2.2. Bony-aligned traditional plan
For the bony-aligned construction of the traditional PTV, the classic van Herk
margin formula was used to construct a margin in the left/right, anterior/posterior, and
superior/inferior directions.

Using manually drawn prostate contours on each bony-

aligned fractional image for each patient, the prostate centroids were computed and
recorded. The systematic and random errors (  and  ) of the centroid shifts were
calculated and used as input to the van Herk formula, given below.
Margin  2.5  0.7

(14)

The values for  and  are given in Table 4, as well as the margin expansion.
These were used to create the PTVvH in the bony-aligned subtrial of the VCT.
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Table 4: The calculated values for  ,  , and the van Herk margin for the NKI dataset used in this
study.

LR (mm)

AP (mm)

SI (mm)



0.5

2.6

2.0



1.0

2.5

2.4

van Herk Margin

2.1

8.4

6.7

Abbreviations: LR=left/right, AP=anterior/posterior, SI=superior/inferior.

4.2.2.2. Bony-aligned plan based on PCA model
The population PCA models of bony-aligned patients for systematic and random
errors were used to sample a synthetic systematic and a random error in a reference
coordinate system. To avoid biasing the VCT, the PCA models were created using only
data from other patients. For example, only systematic error DVFs from patients 2-19
bone
were used in the model used in the creation of the PTVPCA
for the first patient. The

sampled systematic and random errors were then added to create a synthetic
deformation. This deformation was transported to the patient’s local coordinate system
using inter-patient DIR. The synthetic deformation, now in the patient’s local coordinate
system, was used to deform the patient’s prostate planning contour. This deformed
contour represented a realization of one possible instance of the patient’s daily prostate.
This process was repeated (456 times in total) in order to create an organ occupancy
bone
was taken to be
diagram of the prostate overlaid on the planning image. The PTVPCA

the volume that encapsulated 95% of all possible deformations. As coverage followed a
Bernoulli distribution, 456 samples were calculated; this number corresponded to a 95%
confidence interval that the target coverage would be ±2% of the intended threshold. A
flowchart of the bony-aligned VCT subtrial is given in Figure 6.
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Figure 6: Flowchart showing the VCT process for the bony-aligned subtrial.

63

4.2.2.3. Centroid-aligned traditional plan
The second subtrial had the patient aligned daily on the prostate centroid. The
daily anatomies were created in the same manner as the bony setup, but with the extra
step of the aligning the image on the prostate centroid each day. Only translation of the
patient was considered.
For the centroid-aligned traditional plan, the PTVcl was chosen to be a clinically
popular 5 mm margin expansion in all directions except posteriorly, where a 3 mm
expansion was used in an effort to spare the rectum from unnecessary dose. In a study
led by Wen, the authors concluded that this margin is a good choice in IMRT plans, as
judged by a superior complication-free tumor control probability (P+) when compared to
margins of 10 mm/6 mm posteriorly and a 3 mm uniform margin.67
4.2.2.4. Centroid-aligned plan based on PCA model
cent
The PTVPCA
was determined in a manner very similar to that described in Section

4.2.2.2., with the difference being in how the population PCA model was created. The
prostate centroid was used to align each patient’s fractional images to his planning
image.

After this initial alignment, the DVFs associated with these two images,

u  i ,k  i ,0   xi ,0  , were calculated.

From this point, the patient-specific systematic and

random errors were calculated as described in Chapter 2, and the centroid-aligned
population PCA model was created using the methods outlined in Chapter 3.
flowchart for the centroid-aligned subtrial is given in Figure 7.
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A

Figure 7: Flowchart outlining the VCT process for the centroid-aligned based subtrial.
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4.2.3. Planning setup and objectives
For each trial arm of each subtrial, seven 6 MV beams were used to create an
IMRT plan. The beam angles used were 30°, 80°, 130°, 180° (posterior), 230°, 280°,
and 330°, with the isocenter set to the PTV centroid in the planning image.

The

planning objective criteria (Table 5) were identical. Each patient had a prescription
dose to the arm-specific PTV of 86 Gy over 43 fractions.

This prescription was

designed after the dose-escalation planning protocol of Memorial Sloan Kettering.68,69
OAR dose volume objectives were selected to achieve the minimal dose to the OARs
while still providing target coverage.

Universal dose objectives are impossible to

determine for every patient, as some patients present with more favorable anatomies
than do others. In IMRT planning, the optimizer stops once it has met all objectives;
however, this may not be the optimal plan, as normal tissue doses may have been able
to be lowered beyond the planning objectives. To solve this problem and to guide the
optimizer to achieve maximum therapeutic ratio, the bladder and rectum included
generalized equivalent uniform dose (gEUD) as well as conventional DVH objectives.
gEUD is the dose, which if uniformly delivered, gives the same radiobiological effect as
the inhomogeneous dose of interest.70,71 The equation for gEUD is as follows:


gEUD    v j D aj 
 j


1

a

(15)

where v j is the volume of the dose volume bin with dose D j , and a is a tissue doseresponse parameter. For healthy tissues, a is a positive number. In this work, an extra
planning objective was set for the bladder and rectum, calling for a maximum gEUD = 0
Gy ( a  4 ). This objective can never be achieved while still meeting PTV objectives, but
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it is useful in driving down doses to bladder and rectum below their DVH objectives. To
ensure that OAR dose reduction was not achieved at the expense of PTV coverage, a
very low weight (w= 1  10 6 ) was used for the gEUD objectives. The OARs used in the
optimization were those manually contoured on the patient’s planning image.

All

planning and dose calculations were done using Pinnacle treatment planning system
(v9.1, Philips Medical Systems).

The maximum number of iterations used in the

optimization process was set to 50. In addition to the OAR gEUD objectives, the DVH
planning objectives in Table 5 were used for plan optimization.

Table 5: Planning objectives for use in IMRT beam optimization.

Organ

Dose Criteria

PTV

D97≥86 [constrain], D2≤90.7 [80]

Bladder

D70≤19.8 [50], D50≤38.7 [25], D30≤61.9 [25], D20≤69.7 [15], D14≤74 [15],
D9≤79.1 [15], D2≤89.4 [15] , EUDmax=0 [a=4, w= 1  10 6 ]

Rectum

D50≤38.7 [50], D30≤55.5 [25], D20≤69.7 [15], D5≤74.8 [50], D2≤82.6 [50],
Dmax=84.3 [50], EUDmax=0 [a=4, w= 1  10 6 ]

Femur

D1≤54.6 [10]

Ring Structure

Dmax=75.3 [1]

All doses are in Gy, with the objective weights in brackets.

4.2.4. Dose accumulation
Dose accumulation was done using in-house bio-dose accumulator software
within the research computing framework (RCF), described by Fatyga et al.72 For each
patient, the dose accumulator reads in the sequence of Pinnacle computed dose
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distributions (one for each interfraction instance of anatomy), the planning image and its
contours, and the corresponding sequence of 43 synthetic DVFs.

These DVFs

represent the daily anatomies of the patient throughout the whole treatment course.
The dose (which is assumed invariant), was then mapped to the planning image by
each DVF and accumulated for the prostate, bladder, and rectum, creating a DVH for
each of the three organs. The D90, D95, and D97 were reported for the prostate, and the
D50, D30, D20, and D5 were reported for the bladder and rectum. The differences in
these metrics were compared between the two planning arms. Hypothesis testing was
performed in order to assess the significance (p<0.05) of the differences between the
DVH metrics for each arm. For this purpose, a paired t-test was used.
4.3.

Results

bone
and PTVvH comparison
4.3.1. PTVPCA

bone
For every patient, the volume of PTVPCA
was smaller than its corresponding

PTVvH . Across all patients, there was a mean 15.7% (range 10.3 – 23.2%) reduction in
volume size. This reduction in volume is a promising but not definitive indicator of
possible OAR tissue sparing, as this metric gives no information on which areas of the
PTV were being trimmed. A visualization of the direct comparison between the two PTV
expansions versus location is given in Figure 8 for a sample patient. Only one patient is
shown, as the magnitudes and patterns are similar between all patients.

Here, a

colormap representing the PTV margin is overlaid on the manually drawn planning
contour of the prostate. In the area adjacent to the bladder (anterior to the prostate),
the PCA model yields a margin reduction compared to van Herk of 2-3 mm and smaller
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reduction in the left and right directions. However, a substantial (~4 mm) increase in the
margin is suggested by the PCA model in the area adjacent to the rectum.
dosimetric effect of this increased margin was investigated.

69

The

Orientation

Distance to PTVvH

bone
Distance to PTVPCA

Beam’s eye view:
Posterior

Beam’s eye view: Anterior

Beam’s eye view:
Superior
Figure 8: Distance to PTV expansion maps for a sample bony-aligned patient for three different orientations from a beam’s eye view
perspective. The shape is that of the physician-drawn prostate where the color represents the distance to the closest point (distance in
bone
bone
and PTVvH . PTVPCA
offers smaller margins in all locations except against the
mm) for the two different PTV expansions, PTVPCA
rectum (top row), where they can be as large as 13 mm.
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4.3.2. VCT results for bony setup subtrial
The DVHs for three patients are given in Figure 9.

These three patients

represent three possible outcomes: one in which the PCA plan is superior, one in which
the van Herk plan is superior, and one in which they are comparable. In order to
determine any possible benefit for the population of the patients, DVH metrics were
extracted for each patient. The means and standard deviations are presented in Table
6. The PCA and van Herk plans each delivered the prescription dose of at least 86 Gy
to 97% of the prostate. The differences in prostate dose delivery were statistically
insignificant, suggesting that the PCA posterior margin was unnecessarily large, while
the van Herk margin was too large in all other directions. Across the patient population,
the PCA plan delivered significantly less dose to the D30 ( p  7.96 104 ), D20 (

p  4.78 105 ), and D5 ( p  3.45 103 ) of the bladder (mean reduction of 1.9, 2.7, and
1.2 Gy, respectively). For the rectum, the relationship was more complicated. The
rectal dose differences between the two plans were deemed significant for the D50
( p  0.0230 ), D20 ( p  7.51105 ), and D5 ( p  8.03 106 ). On average, the rectum D50
for the PCA plan was lower by 1.0 Gy, but this plan provided higher doses to the D20
and D5 (2.6, and 2.3 Gy, respectively). This implies that the PCA plan is less effective in
reducing the high doses to small subvolumes of the rectum, yet it may help limit lower
doses to larger portions of the rectum. On a patient-by-patient basis, the DVH metrics
investigated are plotted for the prostate, bladder, and rectum in Figure 10. For the
bony-aligned setup, the “better” plan is not easily determined. Using the PCA plan
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represents a tradeoff between lowering the dose to the bladder and giving higher dose
to portions of the rectum.
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a.)

b.)

c.)
Figure 9: Example DVHs for three patients in the bony-aligned VCT subtrial. Dashed
bone
.
lines represent plans using PTVvH while solid lines represent plans using PTVPCA
Curves are given for the prostate (green), bladder (blue), and the rectum (red). Image a)
represents an instance where the van Herk base plan gives a resultant plan that is better
than the PCA based plan. Image b) shows a plan where the plans are comparable. Image
c) shows an instance where the PCA plan is deemed better.
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Table 6: The mean and standard deviation of selected DVH metrics in the prostate, bladder and
rectum over all 19 patients in the bony-aligned setup. The right-hand column gives the difference
of the mean doses. A negative difference indicates a mean dose reduction in plans created using
bone
.
PTVPCA

Prostate

Bladder

Rectum

DVH
Metric

Mean PCA
Dose (Gy)

Mean
Traditional
Dose (Gy)

Mean PCA Dose Traditional Dose
(Gy)

p-value

D97

86.7±2.1

86.3±2.9

0.4

0.130

D95

87.4±1.6

87.1±2.3

0.3

0.408

D90

88.1±1.2

88.0±1.6

0.1

0.532

D50

26.7±15.4

27.5±15.9

-0.8

0.0881

D30

47.9±16.7

49.8±16.9

-1.9

7.96x10-4

D20

63.1±14.5

65.8±13.4

-2.7

4.78x10-5

D5

85.6±3.5

86.8±2.6

-1.2

3.45x10-3

D50

36.0±9.2

37.0±8.5

-1.0

0.0230

D30

56.0±7.4

55.0±7.0

1.0

0.0604

D20

66.8±8.5

64.2±8.1

2.6

7.51x10-5

D5

82.6±4.6

80.3±5.7

2.3

8.03x10-6
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a.)

b.)
Figure 10: Several DVH metrics for the prostate (top), bladder (middle) and rectum
(bottom) for the bony-aligned setup. The PCA based plan doses are the solid dots while
the doses from the van Herk based plan are represented with an x. The dashed
horizontal lines show the planning criteria used with the associated DVH metric.
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cent
PTVcl comparison
4.3.3. PTVPCA and

cent
Similar to the bony-aligned setup, the volume of PTVPCA
was smaller than the

PTVcl for every patient. The mean reduction in volume size was 27.1% (range 20.8 –
37.4%). A visualization of the direct comparison between the two PTV expansions
versus location is given in Figure 11 for a sample patient. Also similar to the bony
cent
setup, the margin to create PTVPCA
is smaller than the margin for PTVcl in every

direction with the exception of posteriorly (adjacent to the rectum). This effect was not
as pronounced, however, in this scenario.
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Orientation

Distance to PTVcl

cent
Distance to PTVPCA

Beam’s eye view: Posterior

Beam’s eye view: Anterior

Beam’s eye view: Superior
Figure 11: Distance to PTV expansion maps for a sample centroid-aligned patient for three different orientations from a beam’s eye
view perspective. The shape is that of the physician drawn prostate where the color represents the distance to the closest point
cent
and PTVcl .
(distance in mm) for the two different PTV expansions, PTVPCA
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4.3.4. VCT results for centroid-aligned setup subtrial
The DVHs for the same three patients as in the bony-aligned setup are given in
Figure 12, this time aligned on the prostate centroid.

The population mean and

standard deviation of selected DVH metrics are presented in Table 7. Similar to the
bony-aligned setup, both centroid-aligned plans delivered, on average, the prescription
dose to 97% of the prostate. While both provided acceptable target coverage, the PCA
plan significantly reduced the dose on average to both the bladder and the rectum for
the DVH metrics investigated; the lone exception was D5 to the rectum.

Here, no

significant difference was found between the two plans. The p-values are given in
Table 7. On a patient-by-patient basis, the four DVH metrics investigated are plotted for
the prostate, bladder, and rectum in Figure 13.
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(a.)

(b.)

(c.)
Figure 12: Example DVHs for three patients in the centroid-aligned VCT subtrial. Dashed
cent
.
lines represent plans using PTVcl while solid lines represent plans using PTVPCA
Curves are given for the prostate (green), bladder (blue), and the rectum (red). Image (a)
represents an instance where the PCA based plan provides less dose coverage to the
prostate. Image (b) shows a plan where the plans are comparable. Image (c) shows an
instance where the PCA plan is deemed better.
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Table 7: The mean and standard deviation of selected DVH metrics in the prostate, bladder, and
rectum over all 19 patients in the centroid-aligned setup. The right-hand column gives the
difference of the mean doses. A negative difference indicates a mean dose reduction in plans
cent
created using PTVPCA
.

Prostate

Bladder

Rectum

DVH
Metric

Mean PCA
Dose (Gy)

Mean
Traditional
Dose (Gy)

Mean PCA Dose
- Traditional
Dose (Gy)

p-value

D97

87.0±1.1

87.4±1.2

-0.4

0.0956

D95

87.4±0.9

88.0±0.8

-0.6

0.0323

D90

88.1±0.7

88.6±0.6

-0.5

0.0117

D50

20.7±13.0

24.0±12.8

-3.3

2.93x10-3

D30

40.0±15.5

45.4±15.0

-5.4

5.81x10-4

D20

54.8±15.1

61.6±13.5

-6.8

6.22x10-5

D5

83.2±5.1

86.1±3.0

-2.9

1.40x10-4

D50

34.0±9.7

37.5±8.3

-3.5

8.84x10-4

D30

50.4±5.8

53.2±4.5

-2.8

1.13x10-4

D20

59.2±6.2

61.0±4.4

-1.8

3.90x10-3

D5

78.0±3.7

77.9±2.8

0.1

0.710
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Figure 13: DVH metrics for the prostate (top), bladder (middle) and rectum (bottom) for
the centroid-aligned patient setup. The PCA based plan doses are the solid dots while
the doses from the 3/5mm plan are represented with an x. The dashed horizontal lines
show the planning criteria used with the associated DVH metric.
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4.4.

Discussion
Results from the centroid-aligned VCT subtrial show that the PCA margin plan

provides adequate prostate dose coverage while reducing the dose to the bladder and
rectum for most (>75%) of the patients when compared to the plan based on the 5/3
mm margin. Importantly, applying the population PCA model to create a patient’s PTV
provides a systematic and reasoned method to determine margins for prostate contouraligned patients. While the formulas of Stroom and van Herk provide this function for
bony-aligned setup, their formulas cannot be applied to the centroid-aligned case. In
clinical practice, the margins currently used for this patient population are created
somewhat arbitrarily and vary widely between clinics. The method described in this
thesis could potentially standardize the practice for margin creation across clinics.
While the results of the VCT were promising for the PCA-based plan in centroidbone
aligned patients, they were less so for patients aligned to bony anatomy. The PTVPCA

was a smaller volume than PTVvH , yet the PCA-based plan offered a modest but
significant dose reduction for the bladder, while raising the dose to parts of the rectum.
In the bony-aligned trial, the PCA based plan resulted in a higher D5 in the rectum for all
patients.

This result is unsurprising, as the PCA model of bony-aligned patients

requires a large (up to 13 mm) margin at the prostate/rectum interface, compared to the
8.4 mm margin computed from the van Herk formula. This difference in margin size did
not compromise the CTV coverage, suggesting that the 95% coverage goal of the PCA
margin is too strict.

Future work will investigate the dosimetric effect of the more

modest coverage goals of 90% and 80%. Another possible explanation for the posterior
margin difference is that the van Herk formula indicates one margin for the posterior and
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anterior directions. The PCA model shows the prostate having larger and more varying
shifts posteriorly. An example of this variability at the rectum is shown in Figure 14.
The pubic symphysis is anterior to the prostate, limiting the amount of motion allowed in
that direction. The lack a motion in the anterior direction may reduce the formulasuggested margin in both the anterior and posterior directions. This would also explain
why the PCA margin is smaller than the van Herk margin in the anterior direction.

Figure 14: An example of the prostate’s variability near the rectum interface for bony-aligned
data. The planning contours for the prostate and rectum are shown in red while the yellow lines
are the physician drawn contours on a treatment day. On this day, the rectum seems to be
pushing the prostate against the pubic symphysis.

This VCT represents a straightforward and simple approach to applying statistical
modeling to the clinical process. The only criterion used to create the PTV was the 95%
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probability of encompassing the prostate. Stroom and van Herk both used dose to the
prostate as their final endpoint. It is possible that the margins could be further reduced
if the dose falloff is taken into consideration. The work of Gordon et al. showed that the
van Herk formula overestimated the necessary margin73 and that this was due to the
formula’s assumption of a perfectly conformal target dose.74 The validity of the PCA
margin developed in this work similarly suffers from not accounting for the dose falloff.
In this VCT, information from the PCA model on the motion of the bladder and
rectum was ignored. A similar method of thresholding the prostate occupancy diagram
could be extended to the OARs to create a planning organ at risk volume (PRV). Due
to the large amounts of deformation in the bladder and rectum, the 95% occupancy
diagram will potentially create large PRVs, which could be unwieldy in the planning
process.

Further research must be done to determine a sufficient thresholding

percentage. Planning objectives may also have to be updated to account for the larger
planning volumes.
4.5.

Conclusion
For two different modes of IGRT daily online setup, the VCT framework was used

to compare the dosimetric differences between a PTV computed from a statistical model
and a PTV commonly used in current clinical practice. For bony-aligned setup, there
was no clear better method between the PCA- and van Herk-based plans for the 19
patients. For centroid-aligned setup, the PCA plan provided proper dose coverage to
the prostate while reducing the dose to the bladder and rectum in most patients when
compared with a semi-uniform margin of 5 mm (3 mm posteriorly).
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5.
5.1.

Conclusion

Patient-specific PCA modeling
Chapter 2 outlined the use of the PCA technique in modeling the patient-specific

random errors of patients undergoing fractionated definitive radiation therapy. By using
the SICLE DIR algorithm, deformations over the entire image volume were modeled.
Previously, only the shapes of select organs (prostate, bladder, and rectum) had been
modeled. Use of PCA technique allows the patient’s random error to be represented by
a linear combination of eigenmodes and expansion coefficients.

These expansion

coefficients are statistically independent of one another, meaning the probability of a
given random error is the same as the probability of selecting the associated set of
expansion coefficients. To compute the expansion coefficient PDFs, KDE was used
with a Gaussian kernel. The PDFs allow for the sampling of synthetic random error
DVFs. To validate the model for all voxels lying within the three organs of interest, the
distributions of vector displacements derived from the original sequence of training
DVFs were compared to those derived from a much larger set of synthetic DVFs
randomly sampled from the patient-specific PCA model. This was done for all patients,
and no significant differences between the vector distributions were found in any voxel.
Patient-specific modeling has potential applications in VCTs, allowing researchers to
create a full fractionation scheme of realistic daily anatomies from a smaller dataset. An
example of this model’s use in probabilistic planning was also given.63
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5.2.

Population PCA modeling
In Chapter 3, the PCA technique was extended from patient-specific modeling to

population modeling of the male pelvis. To do this, a common reference coordinate
system was needed. In this thesis, I present one solution to the difficult problem of
patient-to-patient registration, enabling the patient-specific systematic and random
errors to be mapped to the common reference coordinate system. Due to the difficulty
of interpatient DIR, the systematic and random errors were mapped separately for each
organ (prostate, bladder, and rectum) and stitched together in the reference coordinate
system. The inverse consistency error introduced by mapping patient’s systematic and
random errors to and from the reference coordinate system was determined to be ≤ 0.1
mm for most voxels within the three organs. The well-known parameters of  and  ,
which are measurements of the systematic and random error distributions, were
expanded to the 3D volume covering the entirety of the prostate, bladder, and rectum.
These parameters were calculated for each organ voxel and for both bony-aligned and
prostate centroid-aligned patient setups. The centroid-aligned setup showed smaller
(~2.5x) systematic and random errors within the prostate when compared to bony
alignment. The two setup approaches each had unique distributions of errors. Each
setup showed smaller systematic and random errors near the alignment points (bony
anatomy and prostate centroids).
PCA was used to successfully model the systematic and random errors in a
population of prostate cancer patients. A population systematic and random model
used data from a population of patients to describe the magnitude and likelihood of a
given deformation. Separate models were created using the bony-aligned and prostate
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centroid-aligned data. For all models, the PCA reconstruction error was calculated as
the error introduced by using a limited number of eigenmodes (eigenmodes
representing ≥ 95% of the overall variance). In the voxels within the prostate, the mean
systematic and random errors were all near zero with standard deviations of ≤ 0.56 mm
in all directions. In order to test the model’s ability to represent systematic and random
errors not included in the PCA training data, a leave-one-out study was performed.
Each patient’s systematic and random errors were reconstructed using a PCA model
constructed from data exclusively from other patients. However, the standard deviation
of the voxel differences between the PCA representations of the “left out” patient and
the original systematic DVF was over 2 mm in the bladder anterior-posterior and leftright directions. These standard deviations were smaller for random errors, yet still over
a millimeter in some directions. The larger errors in the systematic error leave-one-out
study indicate that a larger dataset may be necessary to model all modes of systematic
tissue motion.

This work is the first time that both systematic and random tissue

displacements have been modeled for the prostate patient population.
5.3.

Clinical application of the population model
In Chapter 4, I used the population models described in Chapter 3 to create

anisotropic PTV margins and tested their efficacy relative to conventional PTV margin
recipes via a VCT framework. For both bony- and centroid-aligned setups, synthetic
systematic and random prostate DVFs were sampled from their respective PCA models.
These DVFs were then summed to create a synthetic random instance of deformed
central pelvic anatomy.

The interpatient registrations were used to transport each

synthetic prostate DVF to the planning image of the patient and to deform the physician87

drawn planning contours. By averaging the set of bitmaps representing the synthetically
deformed prostate contours, an organ occupancy map was eventually created. For
each patient, a PCA-based PTV was created by thresholding the occupancy map at the
95% level. IMRT treatment plans using the PCA-based PTV were then compared to
plans created using clinically used PTVs. For a bony-aligned setup, the clinically used
PTV was created using the van Herk margin formula found in equation (14).

For

centroid-aligned setup, the clinically used PTV was created using a 5 mm (3 mm
posterior) expansion. In bony-aligned setup, the PCA-based PTVs were found to give a
mean 15.7% (range 10.3-23.2%) reduction in volume when compared with the van Herk
margin PTV. For centroid-aligned setup, the mean volume reduction was 27.1% (range
20.8-37.4%). Plans were applied to a synthetically generated treatment course (using
methods outlined in Chapter 1) for each of the 19 patients in the dataset. In the bonyaligned setup, the PCA- and van Herk-based margin plans each successfully delivered,
on average, the prescription dose to at least 97% the target. The PCA margin plans
exhibited significant decreases (0.8 - 2.7 Gy) in D50, D30, D20, and D5 to the bladder and
the D50 to the rectum, while giving a significantly higher dose to the rectum D20 and D5
(2.6 and 2.3 Gy, respectively). In the centroid-aligned setup, each plan, on average,
delivered the prescription dose to at least 97% of the target while significantly
decreasing (1.8 – 6.8 Gy) all DVH endpoints investigated for the bladder and rectum,
with the exception of the rectum’s D5, where no significant difference was observed. No
loss in target dose coverage was seen for any PTVs used in the VCT, implying that all
were overly generous. This is believed to be caused by extended dose falloff in areas
surrounding the CTV.
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5.4.

Summary
In summation, in this thesis, I outlined and validated a method for statistically

modeling the organ motion of patients undergoing definitive radiation therapy.

The

modeling was performed on an individual basis and then expanded to model the organ
motion of the patient population. A straightforward method was developed to apply the
population modeling in radiation treatment planning to illustrate the clinical utility of
population as wells as individual patient statistical PCA models.

Using the VCT

framework, mixed results were found comparing the dosimetric effects of the model
based treatment planning compared to traditional treatment planning for patients
aligned on bony anatomy. For the subtrial comparing clinically used and PCA-based
PTVs for a simulated prostate centroid alignment, the dosimetric benefit of the PCAbased PTV margin was more pronounced.
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Appendix A: Principal component analysis (PCA)
PCA is a widely used technique in linear algebra that is designed to extract
relevant trends and structure from large datasets. It does so by taking data of a high
dimensionality, and reducing it to a smaller group that encompasses the majority of the
variability in the data. This is done by performing an orthogonal transformation on the
data so that the greatest variance by any projection lies along the first coordinate, the
second greatest variance along the second, and so forth. There are many ways to
perform this analysis, but the one used in this research will be presented here.
Input Data
The formation of the data matrix is essential for a successful implementation of
PCA. Suppose we perform a single measurement of M distinct variables and place
them in a data vector, X1 as shown below.
 x1,1 
x 
1,2 
X1  
  


 x1,M 

(16)

Now suppose that a measurement of these same variables is repeated J times, each
producing a vector similar to that in equation (16). The data matrix to describe these
measurements will now be defined as
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X   X1

X2

 x1,1
x
1,2
 XJ   
 

 x1, M

x2,1
x2,2

x2, M

xJ ,1 
xJ ,2 

 

 xJ , M 



(17)

PCA works on mean subtracted data, so the mean must be computed for each row to
give the mean value matrix, X .
X

1 J
 Xi
J i 1

(18)

The final data matrix operated on by the PCA is
X MS   X1  X X 2  X  X J  X 

(19)

Covariance Matrix
The covariance between two random variables is a description of how these
variables change together. For the random scalar variables x and y , the covariance,

  x, y  , of these two is defined as
  x, y   E  x  E  x    y  E  y   
where E 



is the expectation value.

(20)

Note that when x  y , the covariance is

equivalent to the variance. For a group of variables, like those defined in equation (19),
the M  M sample covariance matrix, Σ , is computed as follows

Σ

1
X MS XTMS
J 1

(21)

This matrix gives the covariance between each data point in the data matrix, X MS , in the
non-diagonal locations and the variances along the diagonal.
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Orthogonal Transformation
PCA

now

eigendecomposition.

requires

that

the

covariance

matrix,

Σ,

undergo

an

Mathematically, this means that the linearly independent

eigenvectors (also called eigenmodes), v , and the eigenvalues,  , are found that
satisfy the well-known eigenvalue equation.

Σv   v

(22)

Because the covariance matrix is symmetric, the spectral theorem guarantees it to be
diagonalizable, and therefore contains J  1 associated pairs of eigenvectors and
eigenvalues.
The eigenvalues give the relative importance of each eigenvector. The fraction
of the variability of the data that can be represented by the associated eigenvector is
given by

i 

i

J 1


i 1

(23)

i

The eigenvalue with the largest fraction is, by definition, the most-principal
component, the second largest eigenvalue with the second most-principal component,
and so forth. Because of this, the eigenvectors are sorted in descending order by their
associated eigenvalues. Typically, only the first L eigenvectors that are needed to
account for the specified minimum percentage of the spectral variance (generally 90 to
95%) are kept.

The discarded eigenvectors are likely associated with noise in the

measurements and not representative of any real data trends.
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Data Reconstruction
PCA can be viewed as optimally changing the basis representation of the data
variability into orthogonal (statistically independent) modes of variation. However, in
most cases, the data must be transformed back into the original basis. This is done
with the Karhunen-Loève transform, which allows an arbitrary data vector, X R , to be
reconstructed as a linear combination of the eigenvectors and scaling coefficients
L

X R   ci v i  X

(24)

i 1

The scaling coefficients are found using the dot product of the eigenvectors and the
data that is to be reconstructed.
ci   X R  X  v i

(25)

This transform can be used to reconstruct the original input data or to model a separate
measurement not included in the original d data. If J  1  L , the original input data can
be reconstructed with no loss of information.
High Dimensional Data
The method outlined above becomes cumbersome when M becomes large, due
in part to the computationally intractable task of diagonalizing a large-scale M  M
covariance matrix, since M is typically the number of voxels in a 3D image (about 107)
for this study’s application. Solutions to this problem have been proposed, such as the
use of singular value decomposition (SVD), which acts directly on the data matrix, X MS
and is computationally stable. However, this work uses a well-known modification of the
traditional PCA method described above, which is beneficial when J  M .75
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details of this method are outlined below.

First, equation (21) is substituted into

equation (22)

1
X MS XTMS v   v
J 1





(26)

Now multiply both sides by X TMS

1
XTMS X MS XTMS v   XTMS v
J 1









(27)

T
And define u  X MS v

1
XTMS X MS u   u
J 1

(28)

Here, it is easy to see that X TMS X MS is the much smaller J  J matrix ( J  19 in this
study), making the eigenvalue problem much simpler to solve. Now multiply both sides
by X MS .

1
X MS XTMS  X MS u     X MS u 
J 1

(29)

Looking within the parenthesis, we see that X MS u is an eigenvector for equation (26).
Thus, once the eigenvectors, u , are found, the full 3D image eigenvectors, v , can be
found by

v  XMS u

(30)

It is important to note that v may not be properly normalized. In the instance where u is
normalized, and extra factor of

1

  J  1

is needed for proper normalization of v .
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Abstract
Purpose:

To create a statistical population-based model of systematic and random pelvic

tissue motion in prostate cancer patients; extend the concepts of systematic and random error
distributions (  and

 , respectively) to three dimensions; and demonstrate that the model

predicts the magnitude, direction, and probability of systematic and random tissue
25

displacements over a 5-7 week course of treatment.
Methods: CT images from 19 patients, each with a single planning image and 8-13 fractional
images, were used in this study. Patient-specific systematic and random tissue displacements
were calculated using deformable image registration (DIR) for two different patient setups, a
bony aligned setup and a prostate-centroid aligned setup. These vectors were transported to a

30

reference coordinate system using inter-patient displacement vector fields (DVFs) mapping
each patient’s planning image to the reference image. The error introduced by mapping to and
from the reference image was quantified. With all patient data in a common coordinate system,

 and  were computed for each voxel within the prostate, bladder, and rectum. Principal
component analysis (PCA) was used to create a statistical model of systematic and random
35

tissue displacements.

The PCA modeling error introduced by only including the principal

components representing 95% of the data variance was investigated and reported. A leave one
out study was performed to investigate the PCA model’s ability to represent systematic and
random tissue motion not included in the PCA training data. Finally, a method for sampling
synthetic deformations from the PCA models was developed, and organ occupancy maps were
40

created and compared between bony and prostrate-centroid aligned patient setups.
Results:

Mapping patient-specific systematic and random tissue errors to and from the

reference coordinate system introduced an error of about 0.2 mm. The magnitudes of  and

 at the reference image prostrate centroid were 1.6 and 1.5 mm, respectively, for prostratecentroid aligned patient setup and 4.6 and 4.1 mm for bony aligned setup.
45

For the PCA

modeling, 11 eigenmodes were needed to describe 95% of the data variance in the systematic
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motion model, while 33 were needed to describe 95% of the variance in the random motion
model. Using the limited number of eigenmodes introduced modeling error in the original data
of less than 1 mm. In the leave one out study, systematic errors within the prostate, bladder,
and rectum not included in the PCA model were reconstructed with absolute mean errors
50

between 1 - 2 mm. Random errors had absolute mean errors between 0.5 - 0.9 mm for each
organ.
Conclusions: Systematic and random pelvic tissue positioning errors were modeled using a
PCA statistical model to within an error of 1-2 mm. The authors developed, implemented and
validated a PCA-based technique to determine the principal modes of systematic and random

55

organ deformation.

In the population under study, the prostate-centroid aligned technique

reduced the  and

 in the areas of clinical interest and gave greater certainty in prostate

localization compared to bony alignment.

Key words
60

PCA, prostate cancer, systematic errors, random errors, population model
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1.

Introduction
Organ motion has long since been a challenge across all anatomical sites in

radiotherapy. Hereafter, “organ motion” will refer to either the displacement or deformation of
65

the anatomy of the treatment day from the planning anatomy. The magnitudes of the motion
have been extensively studied and reported for intrafraction motion, e.g. lung76-78 and
pancreas79,80, as well as interfraction motion, e.g., pelvis1,79,81.

Each site presents different

challenges and requires different motion-management strategies.
It is often beneficial to separate interfraction organ motion into its systematic and random
70

components.

A systematic targeting error is the discrepancy between the anatomy that is

planned and the patient’s mean anatomy throughout their treatment. The daily residual motion
after being corrected for by the systematic component is random targeting error. It has become
common practice to use online image-guided radiotherapy (IGRT) in order to reduce the effect
of the motion on tumor targeting. However, current deterministic corrections use only a rigid
75

shift of the patient, which cannot account for the residual 3D aspects of the motion, such as soft
tissue deformation. The current practice for prostate cancer is daily rigid alignment based on
implanted fiducials. This still leaves residual systematic and random errors introduced by soft
tissue deformation. In most cases, organ rotations are not taken into consideration. Organs at
risk (OARs), such as the highly deformable rectum and bladder, are also not taken into account,

80

even though their motion could cause higher toxicities than anticipated based on the planning
image.

In lung cancer, tracking cycle-to-cycle variations around the mean is difficult and when

technically feasible, is limited to translational isocenter position corrections.
When direct measurement and incorporation of each day’s organ motion into the plan of
the day is not feasible, probabilistic treatment planning (PTP) may be an option. Rather than
85

correcting for each instance of organ motion, from knowledge of the distribution of organ-motion
errors, PTP endeavors to maximize the probability of achieving specified planning goals. These
goals vary, as does the complexity of the planning technique. The simplest and most widely
105
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used PTP method is the clinical target volume (CTV)-to-planning target volume (PTV)
expansion margin. To determine the necessary margin, several formulas have been proposed
90

based on varying assumptions about the dose coverage to most patients in a population,
including normality of the systematic and random error spatial distributions. The most wellknown formula was proposed by van Herk, who sought to deliver 95% of the prescription as the
minimum dose to the CTV for 90% of all patients.39

As input, this formula requires the

distribution of systematic and random errors of the tumor centroid relative to the planning image
95

for the patient population. This formula is limited by its underlying assumptions, as it treats the
tumor as a rigid body, and does not account for the deformable nature of the tumor and
completely ignores OARs (organs at risk). More advanced PTP methods have been developed
to directly incorporate the probability of a given anatomical instance directly into plan
optimization.56,82-84

100

These methods are only as good as their input model describing the

statistics of the patient’s organ motion. Currently, there are few fully 3D statistical models of
organ motion that compute the probability of random and systematic instances of anatomy.
The goal of this paper is to address this void and to extend the concept of systematic
and random error from a single tumor centroid to every voxel within the CTV, as well as the
associated OARs in the male pelvis. This avoids assumptions of the rigidity/non-rigidity of the

105

organs. This paper applies principal component analysis (PCA) modeling to deformable image
registrations (DIR) in order to statistically model these anatomical systematic and random
displacements throughout a patient’s treatment course.

DIR produces displacement vector

fields (DVFs), which quantify the inter-fractional organ motion. While others have used the PCA
technique to investigate patient-specific random tissue displacements46,85 and even random
110

displacements across a population49, this paper is the first to model both random and systematic
error distributions for the prostate patient population.
In this paper, patient-specific systematic and random errors (as described by DVFs), are
transported to a common coordinate system though inter-patient DIR. With each patient’s data
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in a common reference frame, PCA is used to model the principal modes of systematic and
115

random organ motion.

2.

Methods

2.1 Patient dataset
Fan beam computed tomography (CT) images of the male pelvis collected at the
Netherlands Cancer Institute (NKI) from N  19 patients undergoing definitive external beam
120

radiotherapy for prostate cancer were used in this study. All images were anonymized. Each
patient was imaged once before treatment and 8-13 times (median 11) throughout the course of
treatment.

Let Ω ⊂

denote the domain of a CT image. Denote

,

:Ω →

as the CT image

of the ith patient and the kth fractional image were 1 i  N and 0  i  Pi . By convention, k  0
denotes the pretreatment CT image and Pi denotes the number of fraction images of the ith
125

patient.

There were 210 fractional images in this dataset., The 3D prostate, bladder, and

rectum were contoured by a single experienced radiation oncologist on each of these images.
The cutoff for the superior boundary of the rectum was the inferior edge of the iliosacral joints.
Protocols for data acquisition were previously reported by Deurloo.57
For each patient, two different patient setups were investigated. The first approach aligned
130

all fractional images to the planning image by matching a set of bony landmarks. The second
approach aligned all fractional images to the planning image by aligning the prostate centroid in
the fractional images to the prostate centroid in the planning image. The prostrate centroid was
calculated from physician-drawn contours of each image. No rotations were considered in the
initial patient alignment.

135

2.2 Deformable image registration
2.2.1

Intra-patient DIR
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Define h i , k  i ,0 : Ω  Ω as the Eulerian transformation that maps the kth fractional image
of the ith patient

,

to the reference image

,

. Denote u i , k  i ,0 : Ω  Ω as the displacement

vector field (DVF) associated with h i ,k  i ,0 where
140

h i ,k  i ,0  x   x  u i ,k  i ,0  x  for x  

(1)

Deformable image registration (DIR) was used to determine the transformation. This was
done using the SICLE algorithm (small deformation, inverse consistent, linear elastic) using both
grayscale and contour matching for the bladder, prostate, and rectum.58 SICLE’s objective
function contains intensity matching, inverse consistency, and regularizing terms. The intensity
145

matching is done using a sum of squares differences using both CT intensities and contour
information. Contours were incorporated into the algorithm by converting each contour into a
binary mask image. The algorithm simultaneously searches for both forward and inverse DVFs
relating the two input images and their associated contour masks.

The objective function

contains terms penalizing inverse inconsistent registrations. A linear elastic regularizing term is
150

also included in the objective function. The transformation is parameterized using a Fourier
basis. The weighting coefficients of the Fourier bases are the output parameters of SICLE. The
algorithm utilizes a multi-resolution approach, starting off minimizing the objective function on a
coarse grid of the images and iteratively refining the parameters on a finer grid. The resultant
DVFs spanned the whole image with voxel sizes of approximately 1.8x1.8x0.3mm. The images

155

were initially rigidly aligned using the bony anatomy. The physician-drawn contours were used
to validate this algorithm. The output DVFs were used to deform the contours and the Dice
similarity metric was used to compare the deformed contours with the physician drawn ground
truth. This was done for every transformation deforming a fractional to the planning image.
Over all fractions and all patients, resultant Dice similarity indices for the prostate, bladder, and

160

rectum were (mean±SD) 0.92±0.02, 0.95±0.03, and 0.89±0.03 respectively.
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2.2.2

Inter-patient deformable registration and construction of a reference image

Pooling data across patients to create a statistical model of DVF variability in a population
of patients requires a common coordinate system.
patient’s reference image
165

,

This was achieved by deforming each

to a population reference image

. In principle, the resulting

 

inter-patient transformation h  i , k  ref can be used to transport intra-patient DVFs u  i ,k  i ,0  xi ,0
derived from different patients onto the coordinate system of

where they can be indexed

and compared to one another in a common coordinate system.
Inter-patient registration of the pelvic anatomy is extremely challenging for most DIR
algorithms. This is due to many reasons including differences in anatomy, abutting organs in
170

the source image may be separated in the target image or vice versa, and organs may slide
against one another from one image to the next. The SICLE image registration algorithm
assumes that two images can be registered using a continuous transformation parameterized
by the 3D Fourier series. As a result, the SICLE algorithm performs poorly in regions where
abutting organs separate or slide against one another. In these instances, registrations using all

175

organ segmentations simultaneously failed. Consequently, we performed separate single-organ
deformable registrations for the three central pelvic organs (bladder, prostate, and rectum) to
allow for the most accurate registration for each organ.
To derive I ref (with support limited to the three central pelvic structures), SICLE contour
driven registration was performed to register each patient’s planning contours to the

180

corresponding contours of a preselected patient. This preselected patient was chosen for its
lack of abnormal anatomy (i.e. minimal bowel gas, average prostate size) upon visual
inspection. The organ-specific DVFs that map voxels from the preselected I p,0 to every other

I i,0 , i  p were then averaged to calculate the mean organ-specific DVF. The mean DVFs were
then used to deformably map the central organs from I p,0 into I ref , creating a stitched average
109
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simulation image, consisting of binary images of the bladder, rectum, and prostate. We then
deformably registered each of the 19 patient’s central pelvic organs as contoured on planning
images, one at a time, to the corresponding structures on I ref . This yielded the transformations
prostate
, h prostate
, and h rectum
, along with the inverse mappings g bladder
hbladder
 i ,0  ref , g  i ,0  ref , and
i,0ref
i,0ref
i,0ref

g rectum
. These transformations were subsequently used to transfer systematic and random
i ,0   ref
190

statistical information to and from the average reference patient, where the data can be pooled
and compared.

Figure 1. The creation of the reference image. Patient planning images are first registered to a single patient’s
planning image, from which the reference image is then created using the mean deformation.

195

2.3 Development of a statistical model of deformed anatomies
2.3.1

Systematic and random anatomical deformations

We assume that each patient’s DVF describing the mapping of a fractional anatomy to its

 

 

planning anatomy, u  i , k  i ,0  x i ,0 , is the sum of systematic and random components, ui xi ,0

 

and Δu  i , k  i ,0  x i ,0 , respectively. The systematic component is defined as the DVF which
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maps each voxel from its planning image, I i,0 to its location, averaged over its positions in each
daily treatment image, I i,k .

 

ui x i,0 

P

1 i
x
u
Pi k1 i,k i,0 i,0

 

(2)

 

Each patient has a single ui xi ,0 . The day-to-day fluctuations of anatomical deformations

 

about ui xi ,0
205

 

are represented by Δu  i , k  i ,0  x i ,0 , which describes the k-th fraction offset of

 

each voxel x i ,0 from the planning image in treatment fraction k from its mean location, ui xi ,0 ,
during the treatment course.

Δu  i , k  i ,0   xi ,0   u  i , k  i ,0   xi ,0   ui  xi ,0 

 

For brevity, ui xi ,0

 

and Δu  i ,k  i ,0  xi ,0 , are hence referred to as “systematic DVF

component” and “random DVF component,” respectively.
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(3)

These quantities are 3D

generalizations of the systematic and random setup error concepts utilized in the margin
formula by van Herk.39
2.3.2

Transport of patient-specific vector fields into reference coordinate system

 

The systematic and random DVF components, ui xi ,0

 

and Δu  i , k  i ,0  x i ,0 , which are

functions of the patient-specific simulation-image coordinate systems, are transported organ-by215





organ to the reference coordinate system, x ref , using the inter-patient DVFs, u bladder
x ref ,
i ,0   ref

u prostate
x
, and u rectum
x
.
i ,0   ref  ref 
i ,0   ref  ref 

This is done by treating the systematic and random

components as vector-valued images and deforming their vector fields with the inter-patient
DVF.



u iref , prostate  x ref   u i x ref  u prostate
x
i ,0   ref  ref
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This is done for all organs and for the systematic and random components.
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As described below, the resultant components were “stitched” together in the reference
coordinate system to form a single systematic or random error, with support limited to the three
pelvic structures. The single-organ systematic or random error’s support was taken to be any
voxels within the associated organ, plus a 1 cm margin around the organ. The margin was
225

necessary to avoid interpolation errors at the organ surfaces introduced when deforming the
reference contours. The stitching for the systematic and random errors is given mathematically
below.

uiunion ,ref

uirectum ,ref  x ref  if x ref  Rectum+1cm


x
 ref  uibladder ,ref  xref  if xref  Bladder+1cm
 prostate ,ref
 xref  if xref  Prostate+1cm
ui

(5)

, ref
uirectum
 xref  if xref  Rectum+1cm
,j

, ref
 xref  if xref  Bladder+1cm
 xref   ubladder
i, j
 prostate,ref
 xref  if xref  Prostate+1cm
ui , j

(6)

and
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, ref
Δuunion
i, j

Volumes where these margins overlapped were handled using a prioritization. The prostate
took first priority, the bladder second, and the rectum third.

In all, there are N different

N

systematic errors and

 P  210 random errors, all in the reference coordinate system.
i 1

i

2.4 Inverse consistency
235

In order for a population model to have value, information extracted from it in the reference
coordinate system (e.g. randomly sampled DVFs or summary statistics) must be mapped back
to a patient’s local coordinate system. The process of mapping the systematic and random
components to and from the reference coordinate system introduces error, due to the DVF
stitching and the fact that inter-patient transformations are not exactly inverse consistent. The
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impact of these two factors was tested as a whole, and will be referred to subsequently as the
“inverse consistency error”.
In order to quantify inverse consistency error, the systematic and random errors were
mapped to the reference frame, then immediately mapped back to the local patient’s frame,
where they were compared with original.



δio, IC  xi ,0   g oi ,0ref uio ,ref  x ref
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  u

o , patient
i

x 
i ,0

for each xi ,0 , find corresponding x ref  u oref  i ,0 (xi ,0 )  xi ,0



(7)



δio, IC  xi ,0   uio ,ref u oref  i ,0  (xi ,0 )  xi ,0  uio , patient  xi ,0 
uio ,l where o  prostate, bladder, rectum, or union and l = patient or ref coordinate system
where “organ” is a placeholder for the prostate, bladder, and rectum, as each organ is done
separately.

To quantify inverse consistency error, the mean and standard deviation of

δio, IC  xi ,0  was averaged over all voxels within the organ for each patient separately, and over
the population of patients.
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2.5 Quantifying the statistics of systematic and random voxel displacements
The systematic and random error components of the tissue displacement must be
transported to the reference coordinate system in order to get a statistical characterization of the
entire patient population. The characterization is done by generalizing the well known concepts
of group mean, systematic error (  ), and random error (  ), introduced by van Herk to model
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statistical fluctuations of setup error, to three dimensions.

 

The group mean, M x ref , is defined as

M  xref  

1
N

N

u
i 1
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union , ref
i

x 
ref

(8)
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Generalizing the classical definition of van Herk, which was limited to the GTV centroid, we

 

define the systematic tissue displacement error, Σ xref , as a function of location, x ref , in the
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reference image, by

Σ  x ref  



1 N union ,ref
 x ref   M  x ref
 ui
N  1 i 1



2

(9)

 

Similarly, the random error, σ x ref , is calculated as the root mean square over all patients of
the standard deviation of each patient’s daily tissue displacements. Mathematically, it is defined
as
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σ  xref  

1 N 1

N i 1 P  1i

  Δu
Pi

k 1

union , ref
i ,k

 x 

2

ref

(10)

2.6 PCA for constructing probability density functions (PDFs) of deformed anatomies
The goal of this statistical model is to quantify the amount of uncertainty in tissue
displacements across a population of patients.
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This knowledge is potentially useful when

designing a plan resistant to such uncertainties for a patient whose individual tissue
displacements are unknown a priori. Equations (8)-(10), above, assume that each voxel moves
independently of its neighbors. Obviously, voxels within an organ move coherently, giving rise
to significant voxel-to-voxel correlations. The Fourier transformation parameterization and linear
elastic regularization present in the DIR used in this work guarantee this correlation.
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To

incorporate these correlations, the statistics of systematic and random errors were modeled
using the PCA technique in the reference coordinate system. Supposing there are L voxels in
the image, we can define the 3L  N matrix of population mean-subtracted systematic data
matrices are calculated as
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D

280

sys

D

sys
x ref ,i

 Δ1 ( x1 )  Δ N ( x1 ) 
 
  Δ1 (x), , Δi (x), , Δ N (x)   
Δ1 ( xL )  Δ N ( xL ) 





where Δ1 ( x)  u1union ,ref  x   M x ref .

(11)

The columns of Dsys are the group-mean subtracted

patient-specific systematic displacements, while the rows are mean-subtracted systematic
displacements of a specific voxel. The same is done to create the random data matrix, Drand .
From these, their respective covariance matrices are calculated. The covariance matrix is a
measure of each voxel’s correlation to the others, and is calculated by
T
1
Dsys  Dsys 
N 1

Csys 
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Similarly, we can define the 3

 P  L

(12)



matrix D rand   Δu i , j x ref

N



i 1 i

  j  1, , P , i  1, , N 
i

and the corresponding covariance matrix

Crand 

1
N

P
i 1



Drand Drand



T

(13)

i

PCA is an orthogonal transformation, or eigendecomposition, of the covariance matrix, which
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seeks to diagonalize the matrix.

C sys v lsys  lsys v lsys
Crand v lrand  lrand v lrand

(14)

lsys and vlsys denote the lth of N nonzero eigenvalues and eigenvectors, respectively. In practice,
the 3 L  3 L matrices are too large to invert. Hence equations (12) and (13) are multiplied by

D 
sys
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T



or D rand



T

transforming the covariance matrix to easily invertible 19x19 or 212x212

matrices and with 3  L eigenvector matrices.75

The result of each decomposition is an

sys
rand
orthonormal set of basis eigenvectors, v l and vl , that satisfy the eigenvector equation (14).

115

D Vile et al.: Population modeling of systematic and random tissue errors
In principle, any random or systematic deformed instance of 3D anatomy, u

 x  , can be
ref

expressed as a linear combination of these eigenvectors and scalar expansion coefficients, cl .

1
u  x ref  
N
300

Lsys

c v
l 1

l

sys
l

 M  x ref 

(15)

In equation (15), Lsys represents the number of eigenmodes necessary to account for 95% of
the variance in the data. Typically, Lsys  N , reducing the dimensionality of the problem. The
eigenvectors (or eigenmodes) are ordered so that the first principal component, with the largest

l accounts for the most variance possible in the data. The second mode is the orthogonal
vector that accounts for the next largest contribution to variance, and so forth.
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2.7 PCA modeling error
By using a limited number of eigenmodes, some amount of error is introduced when
reconstructing the original set of systematic and random spatial distributions. To quantify this
error, equation (15) and its random counterpart was used to reconstruct each systematic and
random DVF using Lsys or Lrand

310

eigenmodes.

In the x ref coordinate system, each

reconstructed displacement field was compared to the original DVF, and the arithmetic mean
and standard deviation of the voxel-by-voxel differences calculated for each organ. For each
patient, the discrepancies were further averaged over the 8-13 random component DVFs
associated with each patient.
2.8 Leave one out study
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For the PCA model to be useful clinically, it must be able to accurately describe systematic
and random displacement distributions from patients that were not part of the training set.
Nineteen different systematic and random DVF PCA models were built, each using data from 18
patients by excluding each patient in turn.

The scaling expansion coefficients required to

approximate the patient’s systematic and random errors in equation (15) were calculated by
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320



cl  v lsys  u  x ref   M  x ref



(16)

Then, the systematic DVFs for the omitted patient were estimated using equation (15), with
the random DVFs estimated similarly.

This process was repeated for the other patients,

creating 19 different models in total, each created using data from the other patients.
Differences between the DVFs for the 19 omitted patients as reconstructed by PCA and directly
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calculated by SICLE were evaluated separately for each organ in each patient. The mean and
standard deviation of the errors were reported.
2.9 Randomly sampling PCA PDFs and organ occupancy maps
A useful application of the PCA statistical models is the creation of organ occupancy maps.
These maps show the probability of an organ of interest occupying each voxel in a patient’s
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simulation image, taking into account both random and systematic anatomy deformation. To
create these occupancy maps, samples of systematic and random DVFs must be randomly
drawn from the PCA model and then added together in order to create a synthetic deformation.
This is done by creating and sampling from a probability density function (PDF) of the expansion
coefficients, cl , associated with each eigenvector in both the systematic and random
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displacement models. The PDF is created from the histogram of eigenvalues (19 and 210
values for systematic and random DVFs, respectively, for each eigenmode) by the well-known
method of kernel density estimation.60,61 Practically, this is done by using equation (16) to
i
compute the expansion coefficients, cl , i  1,, N for each of the N DVFs in the training set. All

of the coefficients associated with a given eigenvector are grouped together and each is
340

represented by a Gaussian kernel:

   c  ci 2 
l

exp 
pl  c  

2
2


2b
N 2 b i 1


1

N
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(17)
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where b is an adjustable bandwidth parameter set according to the recommendations in
Silverman.62

A typical example is shown in Figure 2.

This is a well known technique for

estimation of the underlying PDF when used in conjunction with PCA.86 This technique has
345

been previously applied in the estimation of DIR uncertainties.59

Figure 2. An example of a PDF built through kernel density estimation (KDE). The final PDF (dashed purple) is
created through superposition of many Gaussian kernels taken from the training data coefficients. This PDF
corresponds to the first eigenmode associated with the prostrate-centroid aligned systematic displacements.

350

It is simple and efficient to sample expansion coefficients to use in equation (15) for
creating synthetic systematic and random tissue DVFs, which when added together, form a
synthetic deformation of the anatomy. This deformation is then used to deform the reference
anatomy, yielding a possible anatomical instance. This process is repeated 1000 times, and the
deformed anatomies are then averaged for each voxel, giving the probability of a given organ

355

occupying that voxel on a given treatment day. This is done for both bony and prostratecentroid aligned setups, and the resultant occupancy maps were compared.
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3.

Results

3.1 Inverse consistency
The results of the inverse consistency on the systematic error are shown for each patient in
360

Figure 3.

 

x i ,0
This shows the mean inverse consistency error, δiorgan
, IC

of the inter-patient

transformations for transporting patient specific systematic error DVFs. Table 1 gives the mean
and standard deviations of the errors across all patients. In all patients, the mean error is 0.2
mm or less resulting in submillimeter discrepancies with standard deviations of 0.1 – 0.3 mm
when averaged over patients.
365

This suggests that the lower limit of meaningful DVF error

modeling is about 0.2 mm with the SICLE code.
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Figure 3. The inverse consistency error for the systematic error in the prostate (blue), bladder (red), and rectum
(green) of each patient in the left-right (LR), anterior-posterior (AP), superior-inferior (SI) directions as well as the
error magnitude. The dot represents the voxel-by-voxel mean error within the organ with the error bars representing
one standard deviation.
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Table 1. Mean and standard deviation of the inverse consistency results for the population modeling of both
systematic and random deformations in the left-right (LR), anterior-posterior (AP), and superior-inferior (SI)
directions.

Systematic

Random

LR (mm)

AP (mm)

SI (mm)

Prostate

0.01±0.08

0.00±0.12

0.01±0.09

Bladder

0.01±0.12

0.02±0.13

0.01±0.11

Rectum

-0.02±0.19

0.00±0.22

0.01±0.10

Prostate

0.00±0.01

0.00±0.07

0.00±0.09

Bladder

0.00±0.03

0.00±0.11

0.00±0.16

Rectum

0.00±0.04

0.00±0.11

0.00±0.10
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3.2 Spatial distribution of systematic and random dispersion parameters
The single-voxel group mean, M , and standard deviations, Σ and σ of the population
distribution of systematic and random voxel displacements as a function of error maps are
shown in Figure 4 when the prostate centroids on each day-of-treatment image set is assumed
380

aligned with the simulation centroid. At the prostate centroid, the magnitudes of the group
mean, systematic error, and random errors are 0.4, 1.6, and 1.5 mm respectively. One would
expect these quantities to be approximately zero. However, this work aligns on the prostate
centroid, and due to asymmetric deformation of the prostate, one can expect that DIR will not
necessarily map the day-of-treatment centroids onto the simulation image centroid.

385

These

errors increase with increasing distance from the point of alignment, with standard deviations as
large as 10 mm in the bladder base and near the rectal-sigmoid colon junction due to variations
in bladder and rectal filling.
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LR

AP

SI

M

Σ

σ
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Figure 4. Sagittal views of the population mean, M , systematic error standard deviation, Σ , and random error
standard deviation , σ , in mm for the left-right (LR), anterior-posterior (AP), and superior-inferior (SI) directions.
The values shown here are for daily patient alignment of the prostate centroid. The characterization maps are in the
reference coordinate system, but overlaid on a sample patient anatomy to give a sense of location within the pelvis.

The results for the bony alignment setup are given in Figure 5. At the prostate centroid,
the group mean, systematic error standard deviation, and random error standard deviation
395

magnitudes are 1.7, 4.6, and 4.1 mm respectively. These are, as expected, larger than the
corresponding values for the prostate centroid setup case. Figure 5 shows a modest trend
towards reduced tissue deformation near adjacent bony structures, although some large errors
are evident, e.g., AP random tissue displacement in bladder neck near the pubic symphysis,
indicating that distances between bladder and rectal surfaces proximal to bones varies

122

D Vile et al.: Population modeling of systematic and random tissue errors
400

significantly. For the prostate, the largest uncertainty is the AP location of the prostate base,
which has a  of about 8 mm.
LR

AP

SI

M

Σ

σ
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Figure 5. Sagittal views of the group mean, M systematic error, Σ , and random error, σ , standard deviations in
mm for the left-right (LR), anterior-posterior (AP), and superior-inferior (SI) directions. The values shown here are
for daily online bony alignment. These quantities are mapped in the reference coordinate system, but overlaid on a
sample patient anatomy to give a sense of location within the pelvis.

3.3 PCA modeling error
The PCA modeling error is shown (see Figure 6 and Table 2) for only the online prostratecentroid alignment case. In order to account for 95% of the variance in the data, Lsys  11 and
410

Lrand  33 eigenmodes were needed. Over all patients, the mean and standard deviations of the
PCA reconstruction error for systematic and random displacements is given in Table 2. The
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mean PCA reconstruction errors were all near zero with standard deviations of approximately
0.5 mm and exceed 1 mm only for a very small number (3.8% for systematic) voxels. In
general, PCA modeling errors are larger than inverse-consistency errors.
Systematic

Random

LR

AP

SI

415

Figure 6: Mean difference between PCA reconstructions and original systematic component DVF along each axis.
For each patient, the dots represent the mean error and the error bars show the standard deviation. The data shown
here is for prostrate-centroid aligned data.
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Table 2. Mean and standard deviation of the PCA reconstruction error for both the systematic and random
deformations in the left-right (LR), anterior-posterior (AP), and superior-inferior (SI) directions, averaged over
patients as well as voxels and daily treatment images for the case of prostrate-centroid alignment.

Systematic

Random

LR (mm)

AP (mm)

SI (mm)

Prostate

0.00±0.33

0.00±0.54

0.00±0.33

Bladder

0.00±0.51

0.00±0.50

0.00±0.40

Rectum

0.00±0.82

0.00±0.78

0.00±0.46

Prostate

-0.01±0.21

0.00±0.36

-0.01±0.23

Bladder

0.04±0.63

0.04±0.85

0.03±0.68

Rectum

-0.03±0.65

0.09±0.79

-0.03±0.48

3.4 Leave one out study
In order to reconstruct the systematic displacements, 19 PCA models were created for the
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leave one out study. As with the PCA modeling error results, only the online prostrate-centroid
alignment case is presented here, as results were similar for the bony alignment case. For most
PCA models, either 10-11 or 32-33 principal components, respectively, were necessary to
account for 95% of the variance in the systematic and random displacement input data. The
average error is quite small, but with significant patient-to-patient variability. The largest mean
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errors (about 2 mm) are bladder and rectal systematic errors. Leave one out errors are much
smaller for the random displacements than those for the systematic, implying that a larger
dataset might be necessary to fully describe the systematic variability in the pelvis.
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Systematic

Random

LR

AP

SI
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Figure 7: Results of the leave one out study for both systematic and random displacements in the case of the online
prostrate-centroid alignment case, for each of the “left-out” patients. The arithmetic means and standard deviations
over organ voxels between the actual DVF and that inferred from equations (16) and (15) are shown.
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Table 3. Mean and standard deviations of the PCA modeling errors evaluated over the 19 “left out” patients in the
leave one out study for the online prostrate-centroid alignment protocol. The mean absolute error is given below the
grand mean and standard deviations.

Prostate

Systematic

Bladder

Rectum

Prostate

Random

Bladder

Rectum

LR (mm)

AP (mm)

SI (mm)

0.01±0.81

-0.05±1.25

-0.03±0.87

0.84

1.42

1.00

-0.26±2.27

0.01±2.08

0.01±1.33

1.19

1.18

0.97

-0.05±1.22

0.12±1.31

-0.11±1.02

2.11

1.83

1.31

0.00±0.71

0.00±0.87

0.00±0.58

0.55

0.76

0.54

0.00±1.14

0.00±1.17

0.00±0.80

0.67

0.72

0.52

0.00±0.89

0.00±0.94

0.00±0.68

0.87

0.91

0.62

3.5 Organ occupancy maps
The organ occupancy maps were calculated for both the prostrate-centroid and bony
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aligned setup are presented in Figure 8. Using prostrate-centroid alignment, the prostate’s
position is known with much greater certainty. The bony alignment shows variable uncertainty
in the prostate’s position over 2 cm in the anterior and posterior directions, compared to 7 mm in
the prostrate-centroid aligned patient. For the bladder and rectum in the prostrate-centroid
aligned setup, the organ can be located with greater certainty in regions bordering the prostate,
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while the bony aligned setup has greater certainty in their location near bony anatomy.
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Axial
Bony Aligned

Sagittal
Centroid Aligned

Bony Aligned

Centroid Aligned

Prostate

Bladder

Rectum

Figure 8: Organ occupancy maps for the prostate, bladder, and rectum for both bony and prostrate-centroid aligned setup. The colormap corresponds to the
probability of a given voxel containing the organ on a given day. These are in the reference coordinate system and are overlaid on a sample patient for ease of
viewing
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4.

Discussion
This paper generalizes the concept of systematic and random displacement errors to

three-dimensional space by calculating them on a voxel by voxel basis. Previously, clinical
practice was limited to calculating these displacements and their statistical distributions at a
single point, generally the prostate centroid or an implanted marker. The assumption is that the
prostate moves as a rigid body. This assumption completely ignores tissue deformation. This
work shows general agreement with the literature on the values of  and

 at the prostate

centroid, as shown in Table 4 for a bony aligned setup. However, our 3D calculation shows that
these numbers are not consistent throughout the prostate, and can vary considerably near the
prostate surface. These differences can potentially create a geometric miss to certain portions
of the prostate during the course of treatment. This work also includes the motion patterns of
the bladder and rectum.
Table 4. Comparison of this study’s  and  values at the prostate centroid with selected values previously
reported in the literature. All values are in mm and are for a bony aligned setup. Abbreviations: LR – left/right, AP
– anterior/posterior, SI – superior/inferior.




Study
van Herk87
Beltran81
Current
study

LR
0.9
0.9
0.9

AP
2.7
3.5
4.0

SI
1.7
3.0
2.4

LR
0.9
1.2
1.2

AP
2.7
2.8
2.5

SI
1.7
2.0
3.3

While this study included 210 sets of random tissue displacements, only 19 systematic
tissue displacements were available for this paper. Obviously, our statistical model is limited by
this input data in the types of deformations that it can represent. A leave one out study was
conducted to try to quantify the ability of the PCA models to correctly describe the systematic
and random organ motion of patient’s not in the PCA training set. This study suggested that the
systematic organ motion could be accurately described to within about 1.5 mm. This suggests
that the 19 systematic error samples used in this study might be too small to fully model all
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possible modes of systematic motion. The random organ motion could be modeled to a much
better accuracy.
Accurate inter- and intra-patient DIRs are necessary in building the statistical model.
The intra-patient registrations were done using both grayscale and contour information of the
fractional images.

These registrations were validated using a Dice metric.

Inter-patient

registrations were a much more difficult process to deal with. Using a similar process to the
intra-patient registrations, some of our registrations failed to converge on a final DVF. These
were due to the large anatomical differences between the patients. As the DIR algorithm used
in this study cannot model DVF discontinuities due to use of Fourier series basis functions, we
adopted an heuristic approach, i.e., independently registering the organs using only contour
information. This approach correctly modeled individual organ shape and relative positions to
one another and the bony pelvis of each patient. However, uncontoured structures, e.g., pelvic
lymph nodes, vascular bundles, seminal vesicles, and pelvic bones, are not included. Nor do
our registrations have the benefit of matching soft-tissue features. This makes our results
dependent on the regularization (linear-elastic constitutive law) of our DIR algorithm and its
ability to deform the organs in a realistic manner. For future work, a finite element based DIR
would appear to be a better option, as it can produce DVFs with support limited to the organs of
interest.
Inter-patient DIR is necessary in this work to transport DVFs in a patient’s coordinate
system to the coordinate system of the reference patient. This need to transport changes in a
single patient to a reference patient or template is a current topic of study called “parallel
transport”.88,89
parallelism.

The idea is to transport vectors along geodesics while retaining vector
In the future, these methods could produce a better method for pooling the

statistics in this study.
While not directly demonstrated in this work, our statistical model has several possible
clinical applications for improving treatment.
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PTP is perhaps the most important such
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application. Conceptually, our PCA model is used to randomly select an ensemble of systematic
and randomly deformed instances of a patient’s anatomy, enabling the optimizer to select the
MLC leaf sequence that maximizes the fraction of deformed instances of anatomy meeting the
treatment goals and constraints.56 In order to do this, some knowledge of the distribution of
displacements must be known a priori. Our statistical model gives detailed information about
this population distribution over all voxels within the three organs of interest.
A more straightforward application of this work is construction of a patient PTV that
represents a more optimal tradeoff between target coverage and normal tissue dose. Currently,
isotropic or pseudo-isotropic margins are used to create the PTV, many times based off of
margin formulas. Also, the van Herk formula cannot be directly applied to the prostrate-centroid
alignment protocol, as the  and

 parameters would be zero. PCA population modeling can

create anisotropic margins for any patient setup that would provide more coverage in areas of
larger deformation and less coverage in areas of minimal deformation. Synthetic systematic
and random displacements could be sampled from our model, transferred to the patient’s
planning image coordinate system, and used to deform their planning contours.

An organ

occupancy diagram can be created for the prostate similar to those presented in this work. This
diagram could be thresholded (covering, for example, 95% of all anatomical variations), and this
volume could be used as the PTV.

5.

Conclusion
The purpose of this work was to create a statistical population model of systematic and

random tissue motion. Patient-specific systematic and random displacements were transported
to a reference coordinate system. In this reference coordinate system, the traditional measures
of systematic and random error distributions,  and

 , were calculated for the prostate,

bladder, and rectum on a voxel by voxel basis for bony and prostrate-centroid aligned patient
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setups. A PCA technique was implemented to determine the principal modes of systematic and
random deformation.
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